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The following table describes the meaning of various abbreviations and acronyms 
used throughout the doctoral dissertation. 
 
Abbreviation Meaning 
AD Axial diffusivity 
ADHD Attention-deficit hyperactivity disorder 
AFP Affective psychoses 
ASD Autism spectrum disorders 
CDC Centers for Disease Control and Prevention 
CNVs Copy number variations 
COS Childhood-onset schizophrenia 
CAFEPS The Child and Adolescent First-Episode Psychosis Study 
CDD Child disintegrative disorder 
CSF Cerebrospinal fluid 
CT Computerized tomography 
DMN Default mode network 
DTI Diffusion tensor imaging 
DSM Diagnostic and statistical manual of mental disorders 
EOP Early-onset psychosis 
FA Fractional anisotropy 
FASD Fetal alcohol spectrum disorders 
FEP First-episode psychosis 
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fMRI Functional magnetic resonance imaging  
GM Gray matter  
HFA High-functioning autistic disorder 
ICD International Statistical Classification of Diseases and 
Related Health Problems 
IQ Intelligence quotient 
LFA Low-functioning autistic disorder 
MD Mean diffusivity 
MRI Magnetic resonance imaging 
NIMH National Institute of Mental Health 
NMR Nuclear magnetic resonance 
NOS Not otherwise specified 
NSS Neurological soft signs 
PANSS Positive and negative syndrome scale 
PDD Pervasive developmental disorder 
PEPs-Img First-episode psychosis-Imaging study 
RD Radial  diffusivity 
RDoC Research Domain Criteria 
ROI Region of interest 
SSD Schizophrenia spectrum disorders 
SVM Support vector machines 
TBV Total brain volume 
US United States 
VBM Voxel-based morphometry 
WM White matter 
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1. INTRODUCTION  
 
 
1.1. MAGNETIC RESONANCE IMAGING AND THE STUDY OF HUMAN 
BRAIN 
 
1.1.1. Introduction to magnetic resonance imaging 
 
Nuclear magnetic resonance (NMR) was discovered in 1946 independently 
by Bloch (Bloch, Hansen, & Packard, 1946) and Purcell (Purcell, Torry, & Pound, 
1946), who were both awarded the Nobel Prize in 1952. The idea to apply NMR 
to in vivo studies dates back to 1968, when the first NMR signals from a live 
animal were produced (Jackson & Langham, 1968). Magnetic resonance imaging 
(MRI) in humans was subsequently developed in the late ‘70s to examine the 
anatomical and pathological macrostructure of the brain (Damadian, Minkoff, & 
Goldsmith, 1978; Mansfield & Maudsley, 1977). This technique provided a step 
forward in the study of human brain relative to computerized tomography (CT), 
due to its ability to display images in any plane and with an increased spatial 
resolution, the non-use of ionizing radiation and the lack of imaging distortion 
resulting from the superposition of bone material (Santa Marta, Sánchez, Pascau, 
& Desco, 2003).  
 
Since then, the development of MRI techniques has offered a window through 
which we can look at the human brain directly and gain understanding of brain 
anatomy and function in health and illness (N.C. Andreasen, 2003). The two main 
groups of MRI techniques that can be applied to the study of human brain are 
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structural MRI, which is sensitive to biophysical properties of local brain tissue, 
and functional MRI (fMRI), which is sensitive to temporally changing neural 
activity.  
 
Structural MRI (usually called ‘MRI’, and henceforth referred to as such), 
exploits the contrast in image intensity distributions between and within different 
tissue types, i.e. gray matter (GM), white matter (WM), and cerebrospinal fluid 
(CSF). These contrast differences allow for the delineation of brain structures 
(Fischl et al., 2002), assessment of shape variations in particular brain regions 
(Styner, Lieberman, Pantazis, & Gerig, 2004), and quantification of local tissue 
volumes. Initially, MRI studies measured global or regional tissue volumes by 
totaling the amount of voxels in manually predefined regions of interest (ROIs). 
These methods were followed up by voxel-based approaches such as voxel-
based morphometry (VBM) (Ashburner & Friston, 2000), which allowed for whole 
brain exploration of structural differences between diagnostic groups on a voxel-
by-voxel basis, and thus were not dependent on manually predefined regions. 
Later on, with the advent of improved image acquisition (e.g., higher field 
strength, higher voxel resolution, and improved GM-WM contrast), additional 
techniques which focused on measuring the thickness, surface area, and 
curvature of the cortex emerged (Fischl & Dale, 2000; Gorczowski et al., 2010), 
providing new information about brain morphology that could be used to detect 
alterations in psychiatric patients.  
 
In parallel with the study of WM volume, diffusion tensor imaging (DTI) 
techniques emerged to provide complementary information on the study of WM 
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and structural connectivity within brain networks. DTI (Basser, Mattiello, & 
LeBihan, 1994; Basser & Pierpaoli, 1998) provides information about the fiber 
tracts in vivo by characterizing the three-dimensional diffusion of water molecules 
in the brain (Alexander, Lee, Lazar, & Field, 2007). Main DTI measurements 
include fractional anisotropy (FA), which reflects the directionality of molecular 
displacement by diffusion and varies between 0 (isotropic diffusion) and 1 
(anisotropic diffusion); axial diffusivity (AD), which reflects diffusivity along the 
longitudinal axis of WM fibers (parallel diffusivity), radial  diffusivity (RD), which 
reflects the diffusion of water perpendicular to WM fibers, and mean diffusivity 
(MD), which describes the rotationally invariant magnitude of water diffusion 
within brain tissue (Alexander et al., 2007). Furthermore, the connectivity 
between brain regions can be mapped more directly by following the dominant 
orientations of the water diffusion using DTI-based tractography (Melhem et al., 
2002).  
 
Functional MRI (fMRI) techniques emerged in the ‘90s and advanced the 
study of brain function by leveraging the relationship between neural activity and 
hemodynamics (Logothetis, 2003; Norris, 2006). Indeed, the study of activation 
of particular brain regions (known as functional segregation) and of the temporal 
co-activation of anatomically distant regions (known as functional connectivity) 
through fMRI has helped characterize how the brain’s responses are mediated 
by connections between brain areas and how these connections change with the 
execution of a particular task or with the presence of a particular symptom or 
behavioural phenotype. (Friston, 2009).  
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In this doctoral dissertation, we will focus on the application of MRI, DTI and 
fMRI, t o the study of human brain and neurodevelopmental disorders. These 
techniques require different analytic procedures and differ with respect to their 
application to the study of human brain (see Table 1). Nevertheless, the 
complementary information they provide is quite helpful, as the relationship 
between structure and function is fundamental to the understanding of brain 
organization (Smith et al., 2004). 
 
Table 1. Characteristics of MRI, DTI and fMRI techniques 
 
MRI 
  
High spatial resolution (submillimeter to millimeter): 
structural information  
Volumetric / morphometric quantification 
 
DTI  Moderate spatial resolution (submillimeter to millimeter): 
information on WM structure 
 
fMRI  Poor spatial resolution (millimeter) 
High temporal resolution (seconds to minutes): 
assessment of function / behaviour through indirect marker 
(blood oxygen) 
Results affected by additional  confounders: 
 Degree of cooperation, anxiety/arousal levels, and 
cognitive strategies used (event-related fMRI 
tasks) 
 Variation in behavioural paradigms across 
laboratories 
Legend: DTI, diffusion tensor imaging; fMRI, functional magnetic resonance 
imaging; MRI, structural magnetic resonance imaging; WM, white matter 
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1.1.2. Applications of MRI techniques to the study of psychiatric disorders 
 
MRI has proved useful in neurology and neurosurgery with a wide range of 
applications, from the identification of structural pathology to their application to 
preoperative neurosurgical planning, intraoperative functional neuronavigation or 
postoperative rehabilitation (Bigler, 1996; Nimsky, Ganslandt, von Keller, & 
Fahlbusch, 2006). However, in psychiatry, despite the significant progress in MRI 
techniques and the breakthroughs in technology and computational methods 
over the past three decades (Wise, 2013), the application of MRI to clinical 
practice has been limited to the identification of potentially reversible ´organic´ 
causes underlying psychiatric symptoms. For example, cerebral tumors are a 
major cause of psychiatric symptoms, especially when the tumor is in the frontal 
or temporal lobes (Wessling, Simosono, Escosa-Bage, & de Las Heras-
Echeverria, 2006). In keeping with this, prior to the Diagnostic and statistical 
manual of mental disorders, 4th edition (DSM-IV), the term ‘organic’ mental 
disorder was (and still is) used by psychiatrists to define psychopathological 
syndromes resulting from a systemic medical or cerebral disorder, as opposed to 
‘functional’ mental disorders, which arise from physiological abnormalities that 
cannot be detected by existing laboratory / imaging procedures (Fleiss, Gurland, 
& Roche, 1976; Hales, Polly, & Orman, 1989) 
 
The development of the Research Diagnostic Criteria in the ‘70s led to the 
innovative DSM-III criteria for clinical use, aimed at building a long-term 
framework through which these - ‘functional’ - psychiatric disorders could be 
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defined and classified based on clinical observation as well as underlying 
physiopathology (Spitzer, Endicott, & Robins, 1978). However, diagnostic 
classifications to date have failed to align with this purpose (T. Insel et al., 2010). 
Indeed, current definitions of psychiatric disorders in classification systems such 
as the International Statistical Classification of Diseases and Related Health 
Problems (ICD-10) or the DSM-5 are still based solely on the observation of 
symptoms and behaviours (American Psychiatric Association, 2013; World 
Health Organisation, 1992) with no laboratory / imaging marker to inform the 
diagnostic process. Although DSM / ICD nomenclature might help clinicians 
communicate about clinical pictures, and may be useful for teaching or legal and 
billing purposes, it seems to have a limited validity, due to the limited 
psychopathological rigor and understanding of the underlying pathophysiology.  
 
In 2010, as the major federal research agency funding mental health research 
in the United States (US), the National Institute of Mental Health (NIMH) 
underscored the potential advantages of a neuroscience-based approach to 
psychiatric classification and tried to reach consensus as to how to achieve this 
goal (T. Insel et al., 2010). A new initiative, the Research Domain Criteria (RDoC) 
project, was launched with the aim of creating a framework for research on 
pathophysiology, especially for genomics and neuroscience, which ultimately will 
inform future classification schemes (National Institute of Mental Health, 2010). 
The main goal was to ensure that psychiatric diagnoses had not only reliability 
but also validity (T. Insel et al., 2010). Clinicians could for example supplement a 
clinical evaluation of what we now call an ‘anxiety disorder’ with data from 
functional or structural MRI or genomic sequencing to determine prognosis and 
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appropriate treatment for each individual patient, analogous to what is done 
routinely today in many other areas of medicine (T. Insel et al., 2010). The 
application of MRI techniques to the study of normal brain development and brain 
physiopathology therefore constitutes an opportunity to achieve this goal. 
 
Among psychiatric disorders, there is a group of conditions that seem to 
emerge from perturbations of normal brain maturation at early stages of 
development, collectively known as neurodevelopmental disorders. In keeping 
with the RDoC initiative, MRI techniques can help advance in the understanding 
of their complex origins and physiopathology, through the study of both the 
normally developing brain and of the structural and functional brain abnormalities 
present in individual with these conditions. 
 
 
1.2. MRI AND THE STUDY OF NEURODEVELOPMENTAL DISORDERS 
 
1.2.1. MRI and the study of normal brain development 
 
1.2.1.1. Normal brain development. Introduction 
 
During the 20th century and the beginning of the 21st century, knowledge 
of the microscopic and macroscopic changes in the brain came almost 
exclusively from the examination of postmortem brain tissue and animal models 
(Kretzschmar, 2009). These tools are still quite helpful as they allow direct 
observation of brain morphometry changes and assessment of changes in the 
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distribution of cell bodies, myelin, and molecular markers within brain tissues, 
complementing and informing one another (Herculano-Houzel, Messeder, 
Fonseca-Azevedo, & Pantoja, 2015; Triarhou, 2013; Zilles, Palomero-Gallagher, 
& Schleicher, 2004).  
 
The above techniques have indeed helped with describing the major 
events occurring at a microscopic and macroscopic level during normal brain 
development (see Figure 1).  
 
Figure 1. Major events during brain development  
 
From (T. R. Insel, 2010). Permission for reprint granted by Nature Publishing Group through 
Copyright Clearance Center (‘CCC’). 
 
 
As shown in Figure 1, normal cortical development involves proliferation, 
migration, arborization (circuit formation) and myelination (T. R. Insel, 2010) with 
the first two processes occurring mostly during prenatal life (e.g. the maximum 
number of neurons is attained around gestational week 28), and the latter two 
continuing through the first two postnatal decades. Circuit formation involves a 
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series of processes itself, such as formation and elimination of synapses, glial 
development and neuron-glia interaction (Sadler & Langman, 2010).  
 
The described microscopic changes in the cerebral cortex result in 
changes detectable at the macroscopic level (see Figure 1). For example, in the 
first months after birth, there is an exponential increase in the number of neural 
stem cells that gives rise to the formation of multiple radial cortical columns. This 
results at a macroscopic level in an increase in the cortical volume through 
expansion of the cortical surface area, without a comparable increase in cortical 
thickness (Rakic, 1988, 2009). At later stages, the number of neurons increases 
linearly within each radial column by asymmetrical divisions of the neural 
progenitors, resulting in an increase in cortical thickness at a macroscopic level 
(Rakic, 2009). Gyrification and sulci formation occur in parallel from 14 weeks of 
gestation onward (Armstrong, Schleicher, Omran, Curtis, & Zilles, 1995) under 
the influence of physical constraints and mechanical factors (Hilgetag & Barbas, 
2005; Regis et al., 2005). The increase in brain volume will continue during 
childhood up until the age of 6–10 years old, when the brain reaches 
approximately 95% of the volume of the adult brain. From this stage, volumetric 
increases will be small (see Figure 1). Indeed, a phase of cortical thinning and 
volume loss will dominate late childhood and adolescence, which might reflect 
the selective elimination of synapses (Huttenlocher & Dabholkar, 1997), probably 
accompanied by a reduction in the number of glial cells. Events occurring at the 
interface between WM and GM, such as the proliferation of myelin into the 
peripheral cortical neuropil and the changes in axonal calibers in childhood and 
adolescence may also influence cortical morphology (Sowell et al., 2004).  
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Of utmost importance in normal brain development is the concept of brain 
plasticity, which refers to the ability to change structure and function through 
experience (Knudsen, 2004). Brain development is extremely sensitive to the 
effect of the environment, especially during restricted temporal windows of 
development called ‘critical or sensitive periods’. For example, an imbalance in 
binocular vision during childhood (a sensitive period in the development of visual 
networks) affects visual perception and leads to amblyopia or ‘lazy eye’ (Fagiolini, 
Jensen, & Champagne, 2009; Knudsen, 2004). Of note, adolescence is one of 
the most critical periods of brain development, as a transitional period for 
individuals to refine and attain cognitive skills necessary to become independent 
adults (Brenhouse & Andersen, 2011). This sensitive period encompasses vast 
changes within the brain in parallel with changes in the environment (e.g. 
increasing academic demands, changes in social relationships), environment 
imparting therefore long-lasting effects on shaping the adult brain (Andersen & 
Teicher, 2008; Chudasama & Robbins, 2006; Marsh et al., 2006). 
 
1.2.1.2. MRI and the study of normal brain development.  
 
In parallel with studies of postmortem brain tissue and animals models, the 
advent of MRI techniques provided a new window through which we could 
observe in vivo the changes that take place in the developing human brain, 
including changes in brain structure, brain connectivity and brain plasticity (N.C. 
Andreasen, 2003). 
 
  INTRODUCTION 
37 
 
MRI and normal brain development. Changes in brain structure 
 
The first cross-sectional MRI studies of typical brain development 
measured regional (e.g. frontal, temporal, hippocampal) volumes and correlated 
these measurements with age (Marsh, Gerber, & Peterson, 2008). These studies 
described a pattern of volume reduction of cortical and subcortical GM from 
childhood to adulthood, after adjusting for normal variation in head size 
(Pfefferbaum et al., 1994), with some exceptions, such as the reported increase 
in amygdala and hippocampal volume with age throughout adolescence (Giedd 
et al., 1996). MRI longitudinal designs followed, being the first ones conducted in 
the Child Psychiatry Branch of the NIMH in the US. In these studies, children 
were scanned at different time points up until the age of 20 years old (Giedd, 
Blumenthal, et al., 1999). A linear increase with age of WM volume and an 
‘‘inverted U-shaped’’ growth trajectory for GM volumes of frontal, parietal, and 
temporal lobes was reported, with GM volumes peaking 1 to 2 years earlier in 
girls than in boys (Giedd, Blumenthal, et al., 1999). Subsequent studies 
conducted mainly (but not only) by the same group consistently showed how GM 
volumes follow heterochronous trajectories, with different brain regions maturing 
at different ages and rates, in a typical ‘back-to front and top-to bottom’, non-
linear and sex-specific pattern with age (see Figure 2) (Brain Development 
Cooperative, 2012; Courchesne et al., 2000; Giedd et al., 2015; Gogtay, Giedd, 
et al., 2004; Lenroot et al., 2007; Raznahan et al., 2011; Raznahan et al., 2014; 
Sowell et al., 2004). For example, the parietal cortex reached peak maturity in 
late childhood (around 7.5 years in girls and 9 in boys), whereas the frontal and 
temporal cortices matured later during adolescence (around 10-11 years, earlier 
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in girls than in boys) (Giedd et al., 2015). Expansion of subcortical structures such 
as basal ganglia or of the hippocampus occurred later – i.e. around late 
adolescence and early adulthood (Raznahan et al., 2014).  
 
Figure 2. Right lateral and top views of the dynamic sequence of GM 
maturation over the cortical surface  
 
From (Gogtay, Giedd, et al., 2004). Permission for reprint granted by National Academy of 
Sciences, U.S.A, Copyright (2004). Legend: The sidebar shows a color representation in units of 
GM volume. Letters depict regions of interest in the cortex that were selected for analyses in each 
hemisphere. GM: gray matter. 
 
 
Studies have also assessed trajectories of cortical thickness, reporting a  
progressive thickening of the cortex from birth to age 6-7 years (Nie, Li, & Shen, 
2013; Nie et al., 2014); thickening of language regions of the frontal (i.e., Broca's 
area) and left temporo-parietal cortices (Wernicke's area) in parallel with a 
widespread thinning in the right frontal and bilateral parietal and occipital 
association cortices (Sowell et al., 2004) from age 5 to 11 years; and a pattern of 
widespread cortical thinning during adolescence (Aleman-Gomez et al., 2013; 
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Mutlu et al., 2013), which is reportedly more prominent in girls in frontal and 
temporal regions (Mutlu et al., 2013). With regard to cortical gyrification, studies 
show that primary and secondary folding is well-developed before birth, tertiary 
folding structures undergo rapid development after birth (Nie et al., 2014), and 
most cortical regions show either constant (i.e. no change) or linearly decreasing 
trajectories from childhood to adulthood (Mutlu et al., 2013). 
 
The NIMH group has also reported that cortical growth trajectories differ in 
terms of complexity across cortical regions, with those with laminar architecture 
(e.g. allocortex, including most limbic areas) showing linear growth trajectories, 
and polysensory and high-order association areas (e.g. isocortex in the prefrontal 
cortex) show more complex (e.g. cubic) developmental trajectories. The latter are 
areas thought to support more complex psychological functions (e.g. working 
memory, cognitive flexibility) (Gogtay et al., 2006; Shaw et al., 2008). This 
description may in fact be much more complicated, as brain systems may have 
multiple critical developmental periods and thus follow more complex 
developmental trajectories (Knudsen, 2004). Recent studies have indeed shown 
how these trajectories may be divergent and vary by topological location (Mutlu 
et al., 2013), for example, within the gyral and sulcal cortex (Vandekar et al., 
2015). Other recent studies have reported a simple linear decline in most cortical 
areas by age 5 years, and all areas by age 8 years, with no cortical thickness 
peak at early adolescence (Ducharme et al., 2015), so the debate about how the 
cortex changes is still very much alive. Regarding the progressive cortical 
thinning during adolescence, a recent study by our group showed that in typically 
developing adolescents cortical geometric features such as thickness, surface 
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area, sulcal width and depth are related and conjointly contribute to this flattening 
of the cortex (Aleman-Gomez et al., 2013). This suggests that cortical thinning 
involves both changes in GM and effects of the maturation of WM (Aleman-
Gomez et al., 2013).  
 
MRI and normal brain development. Changes in brain function and brain 
connectivity 
 
In parallel with MRI studies exploring the structural changes of brain 
systems throughout development, fMRI studies (most of them cross-sectional) 
have investigated the changes in the activity and functional connectivity during 
the development of various brain regions reportedly supporting particular 
cognitive functions. For example, normal acquisition of reading and phonological 
skills throughout childhood and adolescence has been associated with age-
related increases in activation of left frontal and temporal cortices in parallel with 
a protracted anatomical thinning of these regions (Sakai, 2005). Normal 
acquisition of ‘inhibitory control’ skills during childhood has been associated with 
age-related increases in the activation of the prefrontal cortex, along with that of 
anatomically connected subcortical brain regions (Rubia et al., 2000). The 
development of emotional control during adolescence (associated in turn with the 
ability to understand social and emotional cues) has been associated with age-
related increases in the ability to modulate the activation of the amygdala in 
response to emotionally evocative stimuli (e.g. fearful faces) through activation of 
the prefrontal cortex in response to non-emotional salient stimuli (Monk et al., 
2003). 
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DTI and DTI-tractography studies have also been helpful in determining 
WM changes with age in different brain regions, as well as the development of 
network connectivity patterns between brain regions. As such, studies (most of 
them cross-sectional) have shown age-dependent increases in FA (Paus, 
Keshavan, & Giedd, 2008) in frontostriatal regions from childhood to adulthood 
(Marsh et al., 2008). This age-related increase in FA has also been described in 
fronto-temporal regions, the maturation of which seems to be protracted and 
extends well into adulthood (Lebel, Walker, Leemans, Phillips, & Beaulieu, 2008) 
(see Figure 3). 
 
Figure 3. Age-related fractional anisotropy increases (left) and mean 
diffusivity decreases (right) by region-of-interest measured by tractography 
in 202 typically developing subjects 
 
From (Lebel et al., 2008). Permission for reprint granted by Elsevier through Copyright Clearance 
Center (‘CCC’). Legend: FA increases (left) and mean diffusivity decreases (right) by ROI 
measured by tractography in 202 typically developing subjects. ROI: region of interest. 
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MRI and normal brain development. Brain plasticity and the effect of experience 
 
MRI has also allowed for the study of brain plasticity and assessment of 
how experience can shape neurodevelopment. Among numerous examples, one 
longitudinal VBM study showed that medical students who were scanned before 
studying for an exam, while studying, and 3 months after taking the exam, 
showed an increase in posterior and lateral parietal GM volumes during the 
‘learning’ period that stabilized thereafter, while hippocampal GM volume 
increased continuously during the observation period (Draganski et al., 2006).  
 
 
1.2.2. Abnormal brain development. The neurodevelopmental disorders 
 
1.2.2.1. Introduction. The neurodevelopmental disorders 
 
 
All processes of brain development that we have described above 
(neuronal maturation, migration, synaptic pruning, etc.) are the result of a 
heterochronous, tightly-regulated, and genetically-encoded program with clear 
influence from experience / environment. This suggests that any deviation from 
this program early in life may result in the development of aberrant 
neurodevelopmental trajectories and could lead to the emergence of pathology 
later in life (Meyer, Feldon, & Dammann, 2011; Owen, O'Donovan, Thapar, & 
Craddock, 2011).  
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For example, chemical distortions during early development can cause 
significant developmental problems, not only in the brain but at a multi-system 
level. A well-known example is fetal alcohol spectrum disorder (FASD), a group 
of conditions children are born with if the mother drinks heavily during pregnancy 
(Mukherjee, Hollins, & Turk, 2006). These children show varying degrees of 
mental retardation, attention deficit and hyperactivity symptoms, motor problems, 
heart defects and facial abnormalities. Exposure to other environmental risk 
factors (e.g. higher parental age, intrauterine infections, maternal stress, 
childhood maltreatment, deprivation) has also been associated with the 
emergence of aberrant neurodevelopmental trajectories either through a direct 
‘toxic’ effect on brain tissue or through epigenetic mechanisms (i.e. the 
environmental factor altering gene expression in the brain through chromatin 
modifications [Fagiolini et al., 2009]). 
 
Similarly, common genetic variations can confer increased disease 
vulnerability independently or through moderation of the individual's vulnerability 
to early environmental stressors (Caspi et al., 2003). For example, cortical 
thickness and surface area are known to show different neurodevelopmental 
trajectories which are reportedly ‘programmed’ by different sets of genes (C. H. 
Chen et al., 2013; Panizzon et al., 2009). Variation in these genes in conjunction 
with early environmental insults during ‘critical’ developmental periods can lead 
to abnormal developmental trajectories of these cortical components. Abnormal 
maturation of the cortex and constitution of brain networks may, in turn, lead to 
the emergence of abnormal behavioural phenotypes, including different 
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psychopathological manifestations or cognitive deficits (Ecker et al., 2013; 
Raznahan et al., 2012).  
 
Different combinations of these varied symptoms and cognitive deficits are 
present in a group of conditions conceptualised as the ‘neurodevelopmental 
disorders’. In these disorders, the development of the central nervous system is 
disturbed from early stages in life and typically (but not always) manifests in 
childhood or adolescence, leading to major impairments of personal, social, 
academic, and/or occupational functioning (American Psychiatric Association, 
2013). The new DSM-5 classification system has indeed replaced the DSM-IV 
section of ‘Disorders usually first diagnosed in infancy, childhood, or 
adolescence’ with a new chapter entitled ‘Neurodevelopmental Disorders’. This 
chapter includes intellectual disabilities, communication disorders (the latest 
including the new social communication disorder), autism spectrum disorders 
(ASD), attention-deficit hyperactivity disorder (ADHD), specific learning disorders 
(reading, writing and mathematics), motor (including tic) disorders, and other 
specified or unspecified neurodevelopmental disorders (American Psychiatric 
Association, 2013). 
 
The above being said, it is well known that most psychiatric disorders, 
including schizophrenia and other psychotic disorders which do not fall into this 
chapter of ‘neurodevelopmental disorders’, show their first manifestations during 
childhood and adolescence (Kessler et al., 2005; Paus et al., 2008). For example, 
11-18% of individuals with schizophrenia and other psychotic disorders 
experience their first episode before the age of 18 years (Amminger et al., 2011; 
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M. Cannon et al., 1999). This would be congruent with the idea of childhood and 
adolescence being an early window of vulnerability (a sensitive period) in brain 
development and with the idea that these conditions share an abnormal 
neurodevelopmental origin. Studies have indeed shown that patients show 
delays in signs of early neurodevelopment during childhood and adolescence 
before the emergence of the first psychotic episode (McGorry et al., 2006), and 
that there is an ‘exaggeration’ of typical adolescent changes in the brain occurring 
in these patients (J. L. Rapoport & Gogtay, 2008). As such, a 
neurodevelopmental pathophysiology of schizophrenia has been proposed 
(Murray & Lewis, 1987; Weinberger, 1986).  
 
In keeping with this, this doctoral dissertation will focus on two 
neurodevelopmental conditions, ASD and psychotic disorders, and on the 
application of MRI (i) to the study of their complex origins and physiopathology, 
and (ii) as a tool to aid in their identification and management in clinical practice. 
 
1.2.2.2. Schizophrenia and other psychotic disorders 
 
Introduction, epidemiology, clinical features and illness outcome 
 
In the early 19th century, Wilhelm Griesinger and many others believed in 
the idea of a unified psychosis (Einheitspsychose), with distinct disease varieties 
deriving from this single universal madness’ (Berrios & Beer, 1995). However, by 
the early 1850s two French psychiatrists Falret and Morel made the distinction 
between ‘folie circulaire’ (i.e. what we now think of as type I bipolar disorder) and 
‘demence precoce’, a progressive disorder characterized by the presence of 
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social withdrawal, self-neglect and bizarre behaviour (Falret, 1878; Morel, 1860). 
In 1893, the German psychiatrist Emil Kraepelin translated Morel's term 
‘demence precoce’ to ‘dementia precox’, a term that emphasized a particular 
cognitive process (dementia) with an early onset (precox), and distinguished 
these patients from those with ‘manic-depressive insanity’, equivalent to Falret’s 
and Morel’s ‘folie circulaire’. Kraepelin described ‘dementia precox’ as a ‘peculiar 
simple condition of mental weakness of subacute development, characterized by 
delusions and hallucinations, disordered thought, loss of interest in the outside 
world and loss of emotional reactions, and a long-term deteriorating course 
occurring at a youthful age’ (Kraepelin, 1893).  
 
Later on, in 1911, the Swiss psychiatrist Eugen Bleuler coined the term 
‘schizophrenia’ to replace Kraepelin’s term of ‘dementia praecox’, and suggested 
that the primary and main symptoms of this condition would be ambivalence, 
autism (loss of interest in the outside world), affective blunting (loss of emotional 
responses) and altered associations (thought fragmentation), while delusions and 
hallucinations would be secondary symptoms often present but not specific to the 
illness (Bleuler, 1911). In 1950, Kurt Schneider adjusted Bleuler’s definition of this 
condition, as he regarded certain symptoms as particularly indicative of the 
disorder, for example particular types of auditory hallucinations, which were 
labelled as ‘first rank symptoms’ (Schneider, 1959). The Schneiderian concept of 
schizophrenia remained dominant up until the early 21st century diagnostic 
thinking. Indeed, until recently, classifications in psychiatry have used the term 
‘psychotic disorders’ to describe a broad spectrum of conditions - the most 
common of these being schizophrenia - in which individuals present with the 
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hallmark symptoms of abnormal thinking and/or hallucinations. In the DSM-IV-TR 
there was a chapter on ‘Schizophrenia and Other Psychotic Disorders’ (American 
Psychiatric Association, 2000), which included brief psychotic disorder, 
schizophreniform disorder, schizoaffective disorder, delusional disorder, 
psychotic disorder due to a general medical condition, substance-induced 
psychotic disorder, and shared psychotic disorder. The new DSM-5 classification 
system has (i) renamed this chapter ‘schizophrenia spectrum disorders – SSD - 
and other psychotic disorders’ (American Psychiatric Association, 2013), thus 
adding the word ‘spectrum’ to the title, (ii) retained the same basic diagnoses, 
and (iii) eliminated the special treatment of bizarre delusions and special 
hallucinations included in previous DSM editions, as the diagnostic specificity of 
Schneiderian first-rank symptoms for schizophrenia has long been questioned 
(Tandon et al., 2013) 
 
Other psychiatric disorders that do not fall into the category of SSD and 
other psychotic disorders, e.g. brief and transient psychotic disorders, type I 
bipolar disorder (Carlson & Goodwin, 1973) or major depressive episode 
(Ohayon & Schatzberg, 2002) can also present with symptoms of psychosis 
(especially positive psychotic symptoms). This is particularly relevant in young 
people with mood disorders, who frequently present with psychotic symptoms, in 
particular auditory hallucinations (Ulloa et al., 2000).  
 
A broader concept of ‘psychotic disorders’ would therefore include a large 
and heterogeneous group of conditions with varied epidemiology, clinical 
presentation, prognosis and potential outcome. Prevalence figures for psychotic 
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disorders in the general population are variable, with one-year prevalence rates 
of about 0.7% (Widerlov, Lindstrom, & von Knorring, 1997), and lifetime 
prevalence rates up to 3% (Perala et al., 2007). Furthermore, most available data 
are restricted to schizophrenia, with a prevalence of about seven individuals per 
1,000 (McGrath, Saha, Chant, & Welham, 2008). This prevalence is reportedly 
higher in male subjects - male: female ratio of approximately 1.4 (Aleman, Kahn, 
& Selten, 2003; McGrath et al., 2008), in urban as compared to rural settings, 
(McGrath et al., 2008) and in migrants (McGrath et al., 2008), although this may 
be related to ethnicity or to a lower socioeconomic status rather than to the effect 
of migration per se (McGrath et al., 2008). Prevalence rates for bipolar disorder 
vary between 1.5 - 3.9% (in the US) and 1.7% - 3.5% (in Europe) in studies 
including patients with bipolar I and II disorders (Faravelli, Guerrini 
Degl'Innocenti, Aiazzi, Incerpi, & Pallanti, 1990; Grant et al., 2005; Narrow, Rae, 
Robins, & Regier, 2002; Wittchen, Nelson, & Lachner, 1998), with most studies 
reporting an almost equal male to female ratio.  
 
With regard to clinical manifestations, there is significant heterogeneity 
across psychotic disorder categories, with patients presenting with varying sets 
of symptoms, including positive symptoms (hallucinations, delusions and 
disorganized speech and/or behaviour), negative symptoms (such as flat affect, 
poverty of speech, and loss of interests and drive), cognitive symptoms (such as 
deficits in working memory and attention), psychomotor deficits (such as motor 
retardation), and mood symptoms (such as depressed mood) (Tandon, 
Nasrallah, & Keshavan, 2009), in addition to the presence of social or 
occupational dysfunction (American Psychiatric Association, 2013). Within each 
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psychotic disorder category, there is further heterogeneity in terms of clinical 
manifestations, course and treatment response. For example, although almost 
40% of patients with schizophrenia will achieve social or functional recovery 
(Zipursky, Reilly, & Murray, 2013), and some will have a relatively good outcome 
even if medication is discontinued (Wunderink, Nieboer, Wiersma, Sytema, & 
Nienhuis, 2013), there is still a large group of patients at risk of poor outcome, 
such as those presenting with what is called ‘deficit syndrome’ (i.e. prominent 
primary negative symptoms) (Kirkpatrick, Buchanan, Ross, & Carpenter, 2001). 
 
Etiology and physiopathology  
 
The idea of schizophrenia (as the most prevalent psychotic disorder) being 
part of the larger group of neurodevelopmental disorders was proposed in the 
late ‘80s (Murray & Lewis, 1987; Weinberger, 1986). In this disorder, the 
interaction between genetic variation and exposure to early environmental insults 
would increase the risk of the disease (van Os & Murray, 2008). With regard to 
genetic risk, the familial nature of schizophrenia has been well-established, as it 
is known that relatives of individuals with schizophrenia have a higher risk for the 
disease than the general population, the greatest risk being among first-degree 
relatives. Indeed, risk in the general population is below 1%, compared to 6.5% 
in first-degree relatives of patients (Kendler et al., 1993), and rising to over 40% 
in monozygotic twins of affected patients (Cardno et al., 1999). Overall, it seems 
there are more contributing genetic factors than previously thought in both 
schizophrenia and bipolar disorder, and while the effects of most of these factors 
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are small, together they are quite meaningful (International Schizophrenia 
Consortium et al., 2009). 
 
The fact that concordance rates in monozygotic twins is not 100% implies 
the influence of environmental factors. The discovery of numerous environmental 
risk factors in the prenatal and perinatal periods (prenatal exposure to infection 
or obstetric complications) and in the intermediate childhood period (e.g. 
urbanicity, early traumatic events) has been important to the understanding of the 
neurodevelopmental model in schizophrenia (Dean & Murray, 2005). Overall, we 
could postulate that patients probably inherit several risk genes which interact 
with each other and the environment to produce abnormal developmental 
trajectories (Howes et al., 2004; Tandon, Keshavan, & Nasrallah, 2008; van Os, 
Rutten, & Poulton, 2008).  
 
As mentioned previously, from a developmental perspective, adolescence 
may be a critical period in the epigenesis of psychotic disorders (Walker & Bollini, 
2002). According to the ‘two-hit’ hypothesis, genetic vulnerabilities (first ‘hit’) lead 
to an aberrant trajectory (e.g. GM loss or WM growth deficits) early in 
development, followed by a second ‘hit’ around adolescence (typical age of onset 
of psychosis), due to the emergence of new environmental risk factors (e.g. drug 
misuse). Together, the confluence of genetic and environmental factors may be 
critical in determining the onset of a psychotic break during this developmental 
stage (Rapoport et al., 2012). The two-hit hypothesis is supported by prospective 
neuroimaging studies of non-psychotic full siblings of childhood-onset 
schizophrenia (COS) patients. These individuals show a pattern of GM and WM 
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growth deficits in childhood (possibly due to genetic vulnerabilities, the first hit), 
that ‘normalize’ by the time the subjects reach late adolescence, which would 
mean that the second hit is absent or overcome by a response of ‘normalization’ 
of the early GM abnormalities, thus representing a ‘resilient phenotype’ (Gogtay 
et al., 2012; J. L. Rapoport & Gogtay, 2011). 
 
With regard to the observed neuropathological changes in schizophrenia,  
an ‘exaggeration’ of progressive GM loss seen in typically developing individuals 
throughout adolescence and young adulthood has been reported, which may 
reflect glial and vascular rather than purely neuronal changes (J. L. Rapoport & 
Gogtay, 2008), excessive and aberrant synaptic pruning with a reduction of 
neuropil rather than a deficit in the total number of neurons (T. D. Cannon et al., 
2014; Whitford et al., 2007), aberrant neurogenesis, axonal growth or myelination 
(Mauney et al., 2013; van Os, Kenis, & Rutten, 2010). Oxidative damage 
(Fraguas et al., 2012) and a rise in pro-inflammatory status (Garcia-Bueno et al., 
2014) has also been reported in patients with first episodes of psychosis. 
 
MRI and the study of psychotic disorders: what questions have been answered? 
 
Do patients with psychotic disorders show differences in brain 
structure relative to typically developing individuals? Since the first MRI 
studies showing an increased volume of the ventricular system in patients with 
schizophrenia relative to controls (Chua & McKenna, 1995; Raz & Raz, 1990), 
studies have consistently reported structural and functional abnormalities in the 
brains of these patients relative to healthy people of the same age (Arango & 
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Kahn, 2008; Arango et al., 2008). Many MRI studies have scanned patients 
during the first psychotic episode (FEP) and have included samples representing 
different stages of brain development (e.g. childhood to early adulthood). These 
studies are indeed of the utmost importance to gain understanding of the 
physiopathological processes underlying schizophrenia and other psychotic 
disorders. The study of FEP patients avoids the effect of potential confounding 
factors such as duration / chronicity of the illness, years of education and the 
effects of treatment on brain structure and function (N. C. Andreasen, Liu, Ziebell, 
Vora, & Ho, 2013; Navari & Dazzan, 2009; Tomelleri et al., 2009). Most of these 
studies have used cross-sectional designs. Studies in first-episode SSD patients 
have reported focal parietal deficits when the first episode occurs in childhood or 
early-adolescence (Burke, Androutsos, Jogia, Byrne, & Frangou, 2008; 
Greenstein et al., 2006; Thompson et al., 2001) and more widespread GM cortical 
(e.g., frontal, temporal) and subcortical volume and/or thickness deficits when 
onset is in late adolescence or early adulthood (Adriano, Spoletini, Caltagirone, 
& Spalletta, 2010; Giedd, Jeffries, et al., 1999; Jacobsen et al., 1996; Janssen et 
al., 2012; Janssen et al., 2014; Janssen et al., 2008; Narr et al., 2005; Olabi, 
Ellison-Wright, Bullmore, & Lawrie, 2012; Radua et al., 2012; Rimol et al., 2010; 
Rimol et al., 2012; Voets et al., 2008). This pattern has also been reported in 
patients with first-episode affective psychoses (AFP), with alterations being larger 
and more widespread in the SSD group (Arango, Fraguas, & Parellada, 2014; El-
Sayed et al., 2010; Farrow, Whitford, Williams, Gomes, & Harris, 2005; Janssen 
et al., 2014; Janssen et al., 2008). Furthermore, our group has shown that there 
is gyral and sulcal cortical thinning in prefrontal and temporal regions in 
adolescents with first episode early-onset psychosis (EOP), which underlies 
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cortical volume deficits (Janssen et al., 2009). A further study by our group also 
showed that increased prefrontal sulcal width was a mediator between the 
decreased prefrontal thickness and gyrification found in these patients (Janssen 
et al., 2014). 
 
Are structural brain abnormalities in these patients associated with 
symptoms and cognitive deficits? Cross-sectional MRI studies have also 
explored the association between morphometric measurements and the 
presence and severity of the core clinical symptoms and cognitive deficits in 
psychosis. For example, one recent study in adult patients with schizophrenia, 
schizoaffective and bipolar disorder showed that the positive and negative 
syndrome scale (PANSS) - positive subscore was inversely correlated with GM 
volume and thickness of frontal and temporal regions, the PANSS negative 
subscore was inversely correlated with frontal cortical volume and surface area, 
and overall, cortical thickness measurements appeared more strongly associated 
with psychopathology (Padmanabhan et al., 2015), although the reported 
correlations were weak in magnitude. Morphometric abnormalities in the insular 
cortex (a key region for high-order cognitive functions such as the distinction 
between self/non-self) have also been proposed as key to the pathophysiology 
and emergence of symptoms of psychosis (Moran et al., 2014; Palaniyappan & 
Liddle, 2012). Indeed, in schizophrenia patients, an association has been 
reported between insular deficits and severity of negative symptoms (Virupaksha 
et al., 2012). Additionally, insular volume deficits (in cross-sectional studies) and 
increased insular GM loss over time (in longitudinal studies) have been 
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associated with presence and severity of positive symptoms (Moran et al., 2014; 
Takahashi, Wood, Soulsby, McGorry, et al., 2009; Wylie & Tregellas, 2010). 
 
Are brain structural changes in these patients progressive over the 
first stages of the illness? MRI studies using longitudinal designs have proved 
helpful in answering this question.  Recent meta-analyses assessing longitudinal 
brain changes over a 2 to 10-year follow-up period have shown progressive 
decreases over time in cortical GM volume especially in frontal and temporal 
regions in subjects with adult-onset schizophrenia compared to healthy controls 
(Fusar-Poli et al., 2013; Haijma et al., 2013; Olabi et al., 2011; Vita, De Peri, 
Deste, & Sacchetti, 2012). However, fewer studies have investigated the 
longitudinal changes in brain structure occurring in patients with EOP, besides 
for those conducted in the US by the NIMH (Gogtay, Sporn, et al., 2004; Sporn 
et al., 2003), in the United Kingdom (James, James, Smith, & Javaloyes, 2004) 
and in Spain by our research group (Arango et al., 2012; Reig, Moreno, et al., 
2009). Table 2 shows a description of the main characteristics of these EOP 
samples and study designs. Our group recently conducted a meta-analysis of the 
data derived from these studies, and found there was a greater progressive 
frontal GM loss in patients relative to controls over the first few years after illness 
onset (Fraguas, Diaz-Caneja, Pina-Camacho, Janssen, & Arango, 2014). This 
loss was not observed in total brain volume (TBV), parietal, temporal or occipital 
GM volumes, however. Furthermore, age at baseline (the younger the patient, 
the greater the loss of temporal GM volume at follow-up with respect to the control 
group) and schizophrenia diagnosis (greater loss of occipital GM volume at 
follow-up as compared with other psychotic disorders) were reported to be 
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significant moderators of these progressive volume changes in EOP (Fraguas et 
al., 2014). All these MRI findings are particularly relevant insofar as they inform 
the neurodevelopmental vs neurodegenerative hypotheses / models in 
schizophrenia and other psychotic disorders (Arango et al., 2014). Of note, the 
progressive brain changes observed in first episode patients (especially in EOP) 
seem to be more prominent during the first 2 years after the first psychotic 
episode (probably related to secondary variables – e.g. effects of substances or 
medication [Zipursky et al., 2013]), and are related to worse outcomes (Arango 
et al., 2012; van Haren et al., 2007). These findings might be of utmost 
importance to inform research involving agents that prevent these progressive 
brain changes (e.g. agents that regulate the oxidative imbalance) (Fraguas et al., 
2012). 
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Table 2. Summary of MRI longitudinal studies in EOP patients  
Author, year EOP Patients Controls MRIa  
Follow-up 
(y)b 
 n % M Agec 
% 
RH 
Diagnostic criteria 
% 
SCZ 
CPZ 
Equiv. 
Duration 
until MRI (y) 
n % M Agec 
% 
RH 
 
 
James, 2004 16 56.3 16.6 94.1 DSM-III-R 100 281.3 1.55 16 56.3 16.0 58.8 1.5, 3 2.11 
Sporn, 2003d 39 6.,5 15.0 NA DSM-III-R or DSM-IV 100 NA 4.60 43 62.8 14.8 NA 1.5, 1.5 3.40 
Gogtay, 2004a 
(COS)e 
23 82.6 13.9 78.3 DSM-III-R or DSM-IV 100 NA 3.77 38 84.2 13.3 94.7 1.5, 1.5 2.51 
Gogtay, 2004b 
(psychosis NOS)e 
19 84.2 13.3 89.5 DSM-III-R or DSM-IV 0 NA 5.50 38 84.2 13.3 94.7 1.5, 1.5 2.60 
Reig, 2009 21 76.2 15.7 90.5 DSM-IV 38.10 NA 0.27 34 61.2 15.2 85.3 1.5, 1.5 2.02 
Arango, 2012 61 65.6 15.3 91.7 DSM-IV 40.98 217.2 0.28 70 32.9 15.3 87.1 1.5, 1.5 2.13 
Adapted from (Fraguas et al., 2014). Permission for reprint granted by Elsevier through Copyright Clearance Center (‘CCC’). COS, childhood-onset schizophrenia; 
CPZ equiv., chlorpromazine equivalents (mean daily dose of antipsychotic during follow-up); EOP, early-onset psychosis; M, males; MRI, magnetic resonance imaging; 
NA, not available; NOS, not otherwise specified; RH, right-handed; SCZ, schizophrenia. a MRI: Tesla, slice thickness (mm); b Duration of follow-up (years); c Mean age 
at initial MRI (years); d Patients evaluated in Sporn et al. (2003) were also evaluated in Gogtay et al. (2004a) (COS). Here, they were used to conduct different meta-
analyses: Sporn et al. (2003) for TBV, total GM volume, frontal GM volume, parietal GM volume, and temporal GM volume, and Gogtay et al. (2004a) (COS) for 
occipital GM volume; e Healthy controls included in Gogtay et al. (2004a) (COS) and Gogtay et al. (2004b) (psychosis NOS) were also included in Sporn et al. (2003).
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Do patients with psychotic disorders show differences in brain 
connectivity measures relative to typically developing individuals? In 1908, 
Bleuler coined the term schizophrenia (Bleuler, 1908), understanding the disease 
to be the result of the ‘division’ of mental functions. This could amount to the idea 
of abnormal connectivity between different brain regions of patients with 
schizophrenia. The introduction of fMRI and DTI techniques has rescued this 
‘dysconnectivity’ hypothesis, with studies reporting anomalies in the functional 
and structural connectivity of certain brain networks in patients with schizophrenia 
and other psychotic disorders (Stephan, Baldeweg, & Friston, 2006). Although 
results so far have been somewhat inconsistent, data suggest that schizophrenia 
is associated with a widespread connectivity deficit, affecting key network nodes 
known as the rich hub (van den Heuvel et al., 2013), which is the backbone of 
communication between different brain areas, including regions of the default 
mode network (DMN), or fronto-parietal and fronto–striatal-temporal circuits. 
Over this widespread deficit, there would be superimposed functional 
abnormalities at a local / regional level (Baker et al., 2013; Fornito, Zalesky, 
Pantelis, & Bullmore, 2012). DTI studies have shown a parallel alteration in the 
structural connectivity of the described networks (Ellison-Wright & Bullmore, 
2009). These functional and structural connectivity deficits have been reported 
across different psychotic disorders (Baker et al., 2013; Skudlarski et al., 2013), 
and also in relatives of affected individuals, (MacDonald, Thermenos, Barch, & 
Seidman, 2009; Skudlarski et al., 2013), therefore making interesting 
endophenotypes for the study of these neurodevelopmental conditions. 
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1.2.2.3. Autism spectrum disorders 
 
Introduction, epidemiology, clinical features and illness outcomes 
 
As stated in the Introduction to Schizophrenia and psychotic disorders (see 
section 1.2.2.2), Kraepelin´s description of ‘dementia precox’ included a group of 
individuals who presented with a very early-onset form of the disorder. From there 
proceeded a steady rise of individual case reports of juvenile schizophrenia or 
psychosis, including De Sanctis’ children with  ‘demencia precocissima’ (Sanctis, 
1909) or Heller’s ‘dementia infantilis’ (Heller, 1908). Of note, when in 1911, Eugen 
Bleuler (Bleuler, 1911) coined the term ‘schizophrenia’ to replace Kraepelin’s 
term of ‘dementia praecox’, he described in these patients a ‘turning inward into 
the own world’ and a denial of contact, a symptom that he named ‘autism’. For a 
long time ‘autism’ was therefore considered a symptom of schizophrenia, and 
children with early forms of ‘demencia precox’ were reclassified as patients with 
‘childhood schizophrenia’ (Lutz, 1937/38).  
 
It was not until 1943 that Leo Kanner described a particular group of 
children within those with psychosis who had difficulties in establishing 
relationships since the beginning of their lives (Kanner, 1943) and presented with 
‘extreme autistic isolation’ (hence he called it ‘infantile autism’). Independently 
from him and almost in parallel (in 1944) an Austrian psychiatrist, Hans Asperger, 
described a group of children with similar characteristics and coined the term 
‘autistic psychopathy’. His work remained unknown until it was cited in a 
publication by Lorna Wing in 1981 (Wing, 1981). 
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During the ‘50s and ‘60s, and despite Kanner’s delineation of ‘infantile 
autism’ as a separate entity, the terms ‘autism’, ‘childhood schizophrenia’ and 
‘childhood psychosis’ were used to describe the same children, depending on the 
tradition of the institution where the diagnosis was established. Furthermore, 
European and American diagnostic classification systems such as DSM-I (1952), 
DSM-II (1968), ICD-7 (1955), and ICD-8 (1967) still conceptualised autism as a 
form of child psychosis. It was not until 1972 that, based on Kolvin´s studies 
(Kolvin, Ounsted, Humphrey, & McNay, 1971), the differential value of Kanner’s 
autism was recognized by Michael Rutter (Rutter, 1972). Autism and child 
schizophrenia were acknowledged as separate entities, and as a result, in the 
DSM-III classification system (1980) (i) the category of autism was included but, 
to avoid confusion between the schizophrenia symptom ‘autism’ and the disorder 
described by Kanner, the term ‘Pervasive developmental disorder’ (PDD) was 
also initiated; (ii) ‘schizophrenia childhood-type’ disorder was removed and 
lumped together with the adult forms of schizophrenia. The ICD- 9 (1978) also 
recognised autism and childhood schizophrenia as separate diagnostic entities, 
but kept the term ‘psychoses with origin specific to childhood’ to refer to infantile 
autism, childhood disintegrative disorder, and other atypical or unspecified 
childhood psychosis. The autism / schizophrenia distinction was maintained in 
subsequent editions of the DSM and ICD. 
 
After DSM-III and through DSM-III-R (1987), ICD-10 (1992), and DSM-IV 
(1994) classification systems, there was a further refinement of increasingly 
complex criteria for autistic disorder / PDD which resulted in a broadening of the 
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concept of autism. Indeed, in 1979, Lorna Wing had launched the concept of the 
‘autistic continuum or spectrum’ (Wing & Gould, 1979) and, nine years later, Allen 
coined the term ‘autism spectrum disorder’ (Allen, 1988), which took precedence 
over PDD in many grounds and was subsequently used in the DSM-5 (American 
Psychiatric Association, 2013). Indeed, the current DSM-5 classification system 
uses the term ASD to describe a group of neurodevelopmental disorders in which 
affected individuals show early-onset reciprocal interaction and communication 
impairments as the sine qua non symptoms. This group encompasses previous 
DSM-IV-TR groups such as Kanner autism, Asperger syndrome, atypical autism 
and a group of non-specified PDD. 
 
With regard to the clinical presentation of ASD, both ICD-10 (World Health 
Organisation, 1992) and DSM-IV-TR (American Psychiatric Association, 2000) 
classifications include a core triad of impairments in individuals with PDD, i.e. 
impairments in the areas of social interaction (the core / most common deficit in 
ASD) and communication (including impairments in semantic-syntactic language 
comprehension, in the pragmatic use of language, and in prosody of speech 
[Rapin & Dunn, 2003]), and the presence of restricted and repetitive behaviours. 
The DSM-5 revision, however, includes two instead of three main symptoms 
domains: social/communication deficits and fixed interests and repetitive 
behaviours (American Psychiatric Association, 2013). This diagnostic construct 
is supported by numerous factor analytic studies of autism symptoms, in which 
the social and communication domains reportedly emerge as a single factor, and 
the repetitive behaviour domain (including repetitive language) is consistently 
separate from the social and communication domains, see Shuster, Perry, 
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Bebko, & Toplak, 2014 for a review. Other aspects, such as the presence of low 
intelligence quotient or delayed speech are also common but not essential for a 
diagnosis of ASD, and can be applied to individual cases as clinical specifiers. 
ASD is understood as a ‘spectrum’ and therefore includes children with a broad 
range of severities, the degree of severity being one of the clinical specifiers of 
ASD in the DSM-5. 
 
The onset of ASD manifestations can occur in different ways. Some 
individuals show an early onset pattern, i.e. abnormalities in social-
communicative development in the first 12 months or so of life, some present with 
a regressive pattern, in which children develop typically for some period and then 
lose previously developed skills over the first two years of life, and finally, a 
‘plateau’ group displays typical levels of social-communication in the first year, 
but fails to make expected developmental progress over time (Ozonoff et al., 
2011). With regard to ASD outcomes, these are generally regarded as lifelong 
conditions. Children with ASD exhibit varied outcomes and studies have found 
that a combination of intellectual ability and communicative speech at early ages 
are the best predictors of outcome in these individuals (Billstedt, Gillberg, & 
Gillberg, 2005; Eaves & Ho, 2008). 
 
Prevalence rates of ASD have increased dramatically in the last few 
decades, with reported rates increasing from 1/2,500 around 1980 (when autism 
was delineated as a separate entity in DSM-III) to the figure currently used by the 
US Centers for Disease Control and Prevention (CDC), in which 1 in every 110 
children is affected (Baxter et al., 2014; Weintraub, 2011). This is in spite of the 
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dearth of data beyond childhood and adolescence in ASD epidemiological 
studies (Baxter et al., 2014) and the difficulties in detecting / diagnosing this 
condition in very young children. Since this last figure by the CDC, there has been 
ongoing debate over whether the prevalence of this disorder is indeed increasing. 
This debate is out of the scope of this doctoral dissertation and is therefore 
presented as supplemental information in Annex I. As for schizophrenia, there is 
a higher rate of ASD in males as compared to females (Halladay et al., 2015). 
The association of a higher socioeconomic status with ASD has been explained 
by other factors such as the association between living in poorer areas, lower 
access to healthcare, and older age at diagnosis, which could result in lower 
prevalence in this population group (Mandell et al., 2009). 
 
Etiology and physiopathology of ASD 
 
As for schizophrenia and other psychotic disorders, data is progressively 
and robustly accumulating regarding the biological basis of ASD within the 
framework of abnormal neurodevelopment (Parellada et al., 2014). Genetic 
studies indicate a large influence of genetic factors in autism, although the 
condition is not always heritable. For example, complex autism with dysmorphic 
features is more frequently associated with an identifiable genetic abnormality 
than essential autism, but is less heritable (Miles, 2011). Many different genetic 
variants confer risk for autism, with common variants of the genome explaining a 
small part of the variance in autism risk, and rare variants such as copy number 
variations (CNVs) explaining a greater amount of genetic liability, particularly in 
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the case of dysmorphic or intellectually disabled individuals (Parellada et al., 
2014). 
 
With regard to environmental factors and their possible association with 
autism, plenty of potential effectors have been studied (Parellada et al., 2014). 
Some of these (e.g. early exposure to toxic agents – e.g. the insecticide 
chlorpyrifos, rubella infection during pregnancy) account for a very limited number 
of ASD cases but are illustrative as examples of how they can initiate, through 
interplay with genetic vulnerabilities, a pathophysiological cascade starting very 
early in prenatal life and resulting in an autistic phenotype in the first years of life. 
As in schizophrenia, some data support a pro-inflammatory molecular landscape 
in ASD, with an uncertain role for these immune factors initiating or maintaining 
brain disease (Pardo, Vargas, & Zimmerman, 2005). In any case, in vulnerable 
periods of brain development (gestational periods and first years of life), all these 
factors could trigger the pathophysiological pathways leading to abnormal 
developmental trajectories and the emergence of the various autistic phenotypes 
(Parellada et al., 2014).   
 
 
MRI and the study of ASD: what questions have been answered? 
 
Do patients with ASD show differences in brain structure relative to 
typically developing individuals? Over the past 15 years, there has been a 
steady rise in the number of MRI studies examining the brain anatomy in patients 
with ASD, although – as in schizophrenia and other psychotic disorders - findings 
have been inconsistent (Brambilla et al., 2003; Pina-Camacho et al., 2013). 
  INTRODUCTION 
64 
 
Initially cross-sectional and then longitudinal MRI studies on volumetric 
abnormalities comparing samples of different types of PDD and healthy controls 
were the most prevalent type of design. The finding of an early brain overgrowth 
(in early childhood) in ASD is the most consistently replicated volumetric finding 
to date (Courchesne, Campbell, & Solso, 2011; Stanfield et al., 2008) together 
with the increase in volume of cerebellar hemispheres and caudate nucleus and 
the reduction of the corpus callosum volume after initial overgrowth (Frazier & 
Hardan, 2009; Stanfield et al., 2008). More recently, studies have reported 
increased cortical thickness (R. Chen, Jiao, & Herskovits, 2011) and folding 
(Kates, Ikuta, & Burnette, 2009) of the parietal lobe in children with ASD relative 
to healthy controls, whereas reported abnormalities in other brain regions have 
been more inconsistent (R. Chen et al., 2011). 
 
Recent studies have also used longitudinal designs to examine brain 
development in infants with ASD, at high familial risk for ASD, and healthy 
controls, scanning them at 6, 12 and 24 months of age, and incorporating MRI 
and DTI techniques together (Wolff et al., 2012). Promising findings suggest that 
the aberrant development of WM pathways may precede the manifestation of 
autistic symptoms in the first year of life (Wolff et al., 2012). Among other 
examples, corpus callosum overgrowth could be among the earliest neural 
signatures of autism. Indeed, there is an increased thickness of this structure in 
babies who develop ASD relative to children who do not, particularly at 6 months 
of age. Furthermore, differences between unaffected high-risk siblings and 
controls in corpus callosum thickness at 12 months of age point to the presence 
of a subpopulation who may later meet criteria for a neurodevelopmental disorder 
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or to the low-level expression of a shared but developmentally variant phenotypic 
feature (Wolff et al., 2015).  
 
Are structural brain abnormalities in these patients associated with 
symptoms and cognitive deficits? MRI studies in ASD have also assessed the 
association between the described volumetric and morphometric abnormalities 
and the core clinical features of this disorder. Among other examples, larger 
volume of the caudate (Hollander et al., 2005) or thickening of frontal regions 
(Ecker et al., 2013) have been associated with higher severity of repetitive 
behaviours; thickening of frontal regions (Ecker et al., 2013) with higher severity 
of communication difficulties; and smaller amygdala volumes with higher level of 
impairment in social reciprocity (Nacewicz et al., 2006)  However, data are still 
variable and inconsistent and the reported correlations are frequently weak in 
magnitude (Ecker et al., 2013). This may be due to methodological and design 
limitations inherent to MRI studies, but also to the fact that structural brain 
changes do not always encompass changes in behaviour (Brambilla et al., 2003; 
Pina-Camacho et al., 2013). 
 
Do patients with ASD show differences in brain connectivity 
measures relative to typically developing individuals? Functional MRI 
studies in ASD have reported abnormal activation patterns in regions related to 
social cognition tasks (Philip et al., 2012), an overall pattern of long-distance 
‘under connectivity’ (e.g. from frontal to posterior regions) and a pattern of local 
and short-range ‘over connectivity’ (e.g. in visual areas), mainly in adult patients 
(Schipul, Keller, & Just, 2011; Wass, 2011). In parallel, DTI studies have reported 
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abnormal structural connectivity between long-distance WM tracts, such as the 
superior longitudinal fasciculus, corpus callosum and the uncinated fasciculus 
(Aoki, Abe, Nippashi, & Yamasue, 2013; Gozzi et al., 2012). These functional and 
structural connectivity deficits could lead to a lack of effective integration between 
brain regions, and therefore to an ineffective complex information processing 
(Philip et al., 2012). This in turn might lead to the emergence of the varied clinical 
manifestations of ASD (Pina-Camacho et al., 2012). 
 
 
1.2.3. MRI and the neurodevelopmental disorders: what questions have 
not been answered? 
 
1.2.3.1. Introduction 
 
Despite the amount of data provided by MRI studies in relation to the 
structural and functional changes in brains of patients with neurodevelopmental 
disorders, findings have been quite inconsistent, and, to date, there are still 
unanswered questions with regard to the pathophysiology of these conditions. In 
keeping with this, no imaging finding has emerged to date as a sensitive and 
specific marker to inform diagnosis, prognosis or prediction of therapeutic 
response in ASD or psychotic disorders in clinical practice.  
 
The reliability of MRI, DTI and fMRI measurements and the lack of 
replication are the main problems when interpreting data from imaging studies in 
ASD and psychosis. Firstly, differences between groups in brain structure and 
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function reported in these studies are based on averages over groups of 
individuals, which might not reflect the variability among different individuals with 
these conditions. Moreover, study designs often rely on small and sometimes 
quite heterogeneous samples (Button et al., 2013). The study of patients in the 
early stages of the illness (e.g. FEP patients or even those at risk of developing 
psychosis) helps make samples more homogenous. The use of cross-sectional 
instead of longitudinal designs or of different image acquisition protocols, imaging 
processing techniques and statistical analyses also has an impact on the 
reliability of the findings. The problem of small sample sizes may be overcome, 
to some extent, by relying on findings from meta-analysis (Ellison-Wright & 
Bullmore, 2010; Fraguas et al., 2014; Vita et al., 2012). Multicenter designs have 
also become a powerful tool in overcoming this problem and therefore in 
improving the reliability of the findings. However, reported data in multicenter 
studies are affected by the between-scanner variation in the morphometric 
measurements under study (Bartlett & Frost, 2008). For this reason, MRI 
reproducibility studies are recommended in any multicenter study in order to 
determine whether the effect of the site obscures the group differences detected 
(Schnack et al., 2010). 
 
The indirect measure of brain activation (oxygen-dependent changes) 
provided by fMRI, and a number of potential confounders (see Table 1) might 
preclude accurate interpretation of the findings and limit reliability. 
Generalizability of fMRI-derived findings may also be limited by the fact that most 
fMRI task-related studies in ASD and psychosis rely on samples of high-
functioning individuals (i.e. with no mental retardation) (Philip et al., 2012). With 
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regard to DTI or DTI-tractography studies, reliability is also affected by a high 
degree of methodological variability. This is related to the sample selection 
procedure itself, but also to the varied types of measures used to assess WM and 
the different acquisition and processing protocols in these studies. Figure 4 
exemplifies the methodological variability observed in a review of DTI studies in 
ASD (Button et al., 2013; Philip et al., 2012). 
 
Figure 4. Methodological variability described in a review of DTI studies in 
ASD 
 
From (Travers et al., 2012). Permission for reprint granted by John Wiley and Sons through 
Copyright Clearance Center (‘CCC’). Legend: Key features of the 48 empirical studies reviewed 
in this paper, including sample size, how participants were diagnosed with ASD, how participant 
groups were matched, the types DTI measures reported in the studies, the DTI methods, and the 
b-values used for data acquisition. AD, axial diffusivity; ADI-R, Autism Diagnostic Interview-
Revised; ADOS-G, Autism Diagnostic Observation Scale-General; DSM-IV, Diagnostic and 
Statistical Manual of Mental Disorders, 4th Edition; FA, fractional anisotropy; FSIQ, full-scale 
intelligence quotient; HC, head circumference; ICD-10, International Classification of Diseases, 
10th Revision; MD, mean diffusivity; RD, radial diffusivity; ROI, region of interest; TBSS, tract-
based spatial statistics; TD, typically developing; VBA, voxel-based analysis. 
 
Aside from the limitations described above, it could be posited that the 
reason why there are a number of unanswered questions in relation to the 
pathophysiology of neurodevelopmental disorders is that we are probably not 
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asking the right questions. If we want neuroimaging to help unravel the 
relationship between ‘mind and brain’, we must know what questions we are 
asking and just how far we can go in answering them with these techniques. In 
1999, the neuroscientist Stephen Kosslyn argued that to do this, ‘we must devise 
theories, test them, revise, and test again (…), just as in any other branch of 
science’, and that ‘facts about neuroanatomy, particularly about connectivity 
between areas, should have a crucial role in this theory development’ (Kosslyn, 
1999). 
 
This doctoral dissertation will focus on the application of MRI techniques 
to help answer three unanswered questions in the research field of ASD and 
psychotic disorders, and will assess how far we can go in answering these 
questions through the use of these techniques. 
 
 
1.2.3.2. Question 1: How does age at onset influence the structural 
abnormalities found in patients with first episodes of psychosis? 
 
Interpretation of results from previous MRI studies assessing the effect of 
age at first episode on brain structure may be hampered by (i) using age as a 
linear variable and therefore disregarding the non-linear relationship between age 
and brain development (Takahashi, Wood, Soulsby, Kawasaki, et al., 2009; 
Velakoulis et al., 1999); (ii) stratifying cases into adolescent vs adult groups 
instead of treating age as a continuous variable (Kyriakopoulos et al., 2009; 
Tordesillas-Gutierrez et al., 2015), or (iii) using narrow age-range samples of 
patients that do not encompass important stages of brain development (Burke et 
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al., 2008). All in all, when assessing the effect of age at first episode of psychosis 
on the diagnostic-related brain structural deficits, a sample comprising the 
various stages of brain maturation and the use of non-parametric procedures is 
preferred. We do not know of a study assessing the non-linear effect of age on 
brain deficits in FEP patients whose first episode onset ranges from early 
adolescence through adulthood. 
 
 
1.2.3.3. Question 2: Do MRI findings support symptom grouping within 
diagnostic categories in current classification systems?  
 
We have described in the Introduction section how diagnostic classification 
systems in psychiatry, such as the DSM and ICD, have failed to align with findings 
emerging from clinical neuroscience and genetics (T. Insel et al., 2010) and how 
diagnostic categories are described on the basis of clinical / behavioural criteria 
with limited validity, as they are not based on the etiological / physiopathological 
underpinnings to these conditions. As such, the DSM-5 classification system 
proposes that ASD be described on the basis of (i) presence of social and 
communication deficits, as a single set of symptoms and (ii) presence of repetitive 
behaviours / restricted interests, as a different symptom domain.  
 
 To further the understanding of the physiopathology of psychiatric 
disorders, the primary focus of the RDoC initiative is on neural circuitry, with 
levels of analysis progressing upwards from measures of circuitry function to 
clinically relevant variation, or downwards to the genetic and molecular/ cellular 
factors that ultimately influence such function (T. Insel et al., 2010). In keeping 
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with this approach, fMRI and DTI techniques can prove helpful in assessing 
whether there is a neuroanatomical substrate that supports the different clusters 
of behavioural / symptom domains comprising the current ASD category.  
 
1.2.3.4. Question 3: Can MRI help in the prediction of psychosis outcomes 
(e.g. diagnostic outcomes) and therefore be applied in clinical settings as 
a tool to inform prediction statements? 
 
The overlap and lack of specificity of symptoms during a FEP, and the fact 
that current diagnostic classifications require a temporal criterion for the 
diagnosis of psychotic disorders (which makes initial diagnoses for these patients 
relatively unstable) (Bromet, Naz, Fochtmann, Carlson, & Tanenberg-Karant, 
2005; Castro-Fornieles et al., 2011; Menezes & Milovan, 2000; Schwartz et al., 
2000) makes the early distinction between SSD and other psychotic disorders 
very difficult in clinical practice  (Craddock & Owen, 2010). For this reason, 
studies that help to identify predictors of diagnostic outcomes at a very early stage 
of the illness should be a priority, as an early and accurate diagnosis enables 
early optimization of treatment and accurate use of prognostic statements for 
patients. 
 
Other fields of medicine have demonstrated that clinical prediction, 
especially in complex disorders, often requires a combination of multiple 
measurements from different sources (Sperling & Johnson, 2013). To this end, 
prediction methodologies based on high-dimensional multivariate statistical 
approaches and including a combination of multiple clinical and biological (e.g. 
  INTRODUCTION 
72 
 
MRI data) seem promising, as they can potentially improve prediction accuracy 
at the early stages of the illness (Johnston, Mwangi, Matthews, Coghill, & Steele, 
2013). The identification of these predictors may (i) help refine current diagnostic 
classification systems through sensitive and specific imaging markers in line with 
the RDoC initiative, (ii) guide clinicians in their practice to inform differential 
diagnosis, choice of appropriate treatment, and prediction of functional outcomes 
at early stages of the illness. We do not know of a study using support vector 
machines (SVMs) - a high-dimensional multivariate statistical tool - to identify 
particular variables from different sources to predict a diagnostic outcome of SSD 
in the early stages of an early-onset FEP.
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2. OBJECTIVES 
 
General Objective   
 
To advance in the study of the physiopathology and illness outcomes of two of 
the hallmark neurodevelopmental disorders, schizophrenia / psychotic disorders, 
and ASD, through the use of MRI techniques.  
 
Specific Objectives 
 
 To determine whether age at first episode has a non-linear effect on the 
diagnosis-related structural abnormalities detected in FEP.  
 
 To assess whether results from fMRI and DTI studies support the symptom 
grouping / clustering proposed by the DSM-5 for the new ASD diagnostic 
category. 
 
 
 To predict a SSD diagnostic outcome in FEP patients using volumetric MRI 
data, alone or in combination with various sets of clinical, 
neuropsychological, and biochemical data. 
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3. HYPOTHESES 
 
 Diagnosis-related volume and thickness abnormalities are dependent on 
the age at first episode of psychosis.  
 
 The dependency of structural abnormalities on age at first episode follows 
a non-linear curve. 
 
 In patients with ASD, social and communication deficits are associated 
with shared abnormalities in functional and structural connectivity in the 
same brain regions/ networks, so they can be collapsed into a single 
symptom domain. The affected networks are different than those 
associated with the presence of repetitive behaviours and restricted 
interests. 
 
 
 Combined clinical, cognitive and volumetric MRI data can accurately 
predict a diagnostic outcome of SSD in patients with early-onset FEP.
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4. METHODS 
 
This doctoral dissertation consists of three published articles authored by the 
doctoral student, including one systematic review and two original articles (please 
refer to Section 5. Publications).
   
 
 
 
 
  
 
 
5.    PUBLICATIONS 
  
  
  
  PUBLICATIONS 
87 
 
5. PUBLICATIONS 
 
5.1. PUBLICATION # 1 
 
Pina-Camacho L., Del Rey-Mejias A., Janssen J., Bioque M., González-Pinto A.,  
Arango C., Lobo A., Sarró S., Desco M., Sanjuan J., Lacalle-Aurioles M., Cuesta 
MJ., Saiz-Ruiz J., Bernardo M., Parellada M., and the PEPs group. Age at First 
Episode Modulates Diagnosis-Related Structural Brain Abnormalities in 
Psychosis. Schizophrenia Bulletin (in press), doi:10.1093/schbul/sbv128.  
 
 
   
 
 
 
   PUBLICATIONS 
89 
 
5.2. PUBLICATION # 2 
 
Pina-Camacho L., Villero S.,  Fraguas D., Boada L., Janssen J., Navas-Sánchez 
FJ., Mayoral M., Llorente C., Arango C., Parellada M. Autism Spectrum Disorder: 
Does neuroimaging support the DSM-5 proposal for a symptom dyad? A 
systematic review of functional magnetic resonance imaging and diffusion tensor 
imaging studies. Journal of Autism and Developmental Disorders 42(7):1326-41, 
2012. 
 
   
 
 
 
 
 
PUBLICATIONS 
   
91 
 
5.3. PUBLICATION # 3 
 
Pina-Camacho L., García-Prieto J., Parellada M., Castro-Fornieles J., Gonzalez-
Pinto AM., Bombin I., Graell M., Paya B., Rapado-Castro M., Janssen J., Baeza 
I., Del Pozo F., Desco M., Arango C. Predictors of Schizophrenia Spectrum 
Disorders in Early-onset First Episodes of Psychosis: A Support Vector Machine 
Model. European Child and Adolescent Psychiatry 24:427–440, 2015. 
   
 
 
 
 
 
  
 
 
6.     DISCUSSION 
  
  
  
DISCUSSION 
95 
 
6. DISCUSSION 
 
The studies that are part of this doctoral dissertation present an advance in 
the study of the physiopathology of two of the hallmark neurodevelopmental 
disorders, schizophrenia / psychotic disorders, and ASD, through the use of MRI 
techniques. The main findings of these studies can be summarized as follows: 
 
 
1. Diagnosis-related volume / thickness abnormalities in patients with FEP 
are mainly present in brain regions undergoing maturation at each particular 
developmental stage. Age at first episode modulates these abnormalities in a 
nonlinear manner.  
 
2. Results from fMRI and DTI studies partially support the new ASD symptom 
dyad proposed by the DSM-5. Data support the presence of separate 
neuroanatomical substrates for the ‘social communication’ and ‘repetitive 
behaviour/restricted interest’ symptom domains that comprise the dyad. There 
are also separate neuroanatomical substrates for syntactic and pragmatic 
language impairments, which is congruent with the DSM-5 inclusion of syntactic 
language impairment as an independent clinical specifier. However, there is a 
shared neuroanatomical substrate for social and pragmatic language deficits, 
which suggests that an explicit mention of pragmatic language deficits should be 
included within this ‘social communication’ cluster. 
 
3. An SVM model containing a combination of clinical and 
neuropsychological variables has the highest predictive value for a diagnostic 
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outcome of SSD in patients with early-onset FEP. MRI volumetric data do not add 
to the predictive value. SVMs could prove helpful in predicting diagnostic 
outcomes in patients with FEP.  
 
 
Findings derived from the first MRI study (PEPs-Img study) are in keeping 
with the neurodevelopmental model of schizophrenia / psychotic disorders, 
as they show an interaction between brain maturation events and the 
morphometric abnormalities detected in FEP. As such, when SSD starts after 
early adolescence (around 15–18 years), no volume / thickness abnormalities are 
found in cases relative to controls in the parietal lobe (a brain region that reaches 
peak maturity in late childhood) (Giedd et al., 2015) but do exist in frontal and 
temporal lobes (volume / thickness deficits) and in ventricular system and basal 
ganglia (volume enlargements). Similarly, first-episode AFP patients showed 
smaller cingulate cortex volumes and thicker temporal cortex only at early ages. 
Findings derived from the third study also reinforce the neurodevelopmental 
hypothesis of psychotic disorders, specifically in SSD. Indeed, in this study we 
found that prevalence of obstetric complications was one of the first-ranked 
predictors amongst the 243 variables demonstrating high predictive value for an 
SSD diagnostic outcome. Among other authors, Mary Cannon and colleagues 
have shown that obstetric complications are one of the best-replicated 
‘environmental’ risk factors for schizophrenia (M. Cannon, Jones, & Murray, 2002; 
Clarke, Harley, & Cannon, 2006). Moreover, among the selected 243 variables 
not shown in Table 4 of the third article, we also found that an arrest of certain 
early developmental milestones (e.g. motor development impairment, history of 
enuresis, learning or reading difficulties) and a previous diagnosis of other 
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neurodevelopmental disorders such as ADHD were also good predictors of SSD, 
which is in keeping with the neurodevelopmental hypothesis as well as with the 
‘staging model’ in schizophrenia (McGorry, Hickie, Yung, Pantelis, & Jackson, 
2006), which posits that during the pre-morbid phase preceding the prodrome 
and the psychotic episode it is possible to identify such delays in signs of early 
neurodevelopment in these patients.  
 
With regard to structural brain abnormalities in FEP patients, the PEPs-
Img study (publication # 1) presents an advance in that it shows divergent brain 
abnormalities in early- and late-onset FEP patients relative to healthy controls. 
Except for the increased volume of the ventricular system and the - less 
consistently reported - decreased volume of prefrontal lobe in patients with first-
episode schizophrenia relative to controls (El-Sayed et al., 2010; Farrow, 
Whitford, Williams, Gomes, & Harris, 2005; Janssen et al., 2012; Janssen et al., 
2014; Narr et al., 2005; Radua et al., 2012; Voets et al., 2008), results have been 
inconsistent among previous MRI studies. Many of these were using age at first 
episode as a categorical discrimination factor for comparing FEP patients (e.g. 
adolescent vs adult groups) and healthy controls, were including patients with 
first episode onset under and over 20 years, or were simply relying on narrow 
age-range samples that do not encompass important stages of brain 
development. The PEPs-Img study demonstrates that in order to further the 
understanding of the physiopathology of schizophrenia and other psychotic 
disorders, a sample comprising the various stages of brain maturation at the first 
stages of the illness is preferred. Moreover, our study may inform future MRI 
study designs as it indicates that disregarding the non-linear relationship of age 
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with brain development may lead to finding no or significantly less marked 
differences among diagnostic groups.  
 
In this first publication, we discussed how the onset of positive psychotic 
symptoms may not be reflective of the actual onset of psychosis itself, and 
furthermore, how the reported brain abnormalities in this study could be 
representing to some extent the effect of both the emergence and progression 
of psychosis over the initial stages of the psychotic break (Pantelis et al., 2005). 
Studies should explore whether brain deficits that are already present at first 
positive psychotic break predate the emergence of psychosis - and thus 
represent a risk marker for illness onset - or if they represent a cause or effect of 
the emergence of psychosis, as this remains unclear. This issue highlights the 
need for longitudinal studies in FEP patients as well as in subjects at high-risk for 
developing psychosis, in order to assess in detail abnormal brain developmental 
trajectories in these individuals. The publication presented here was based on 
cross-sectional data obtained at the baseline visit for the PEPs-Img study, but 
patients and controls have since been re-scanned at the 2-year follow-up visit, 
which will provide further insights into the progressive brain changes present in 
these patients during the first stages of the illness. In addition, this longitudinal 
design will help advance in the understanding on how these brain deficits present 
at first episode affect the clinical phenotype and the course of illness (Arango et 
al., 2008). 
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With regard to the diagnosis-related differences within psychosis 
subgroups, results have been contradictory to date and the studies within this 
doctoral dissertation do not help resolve these inconsistencies. In the first 
publication of this dissertation, contrary to our expectations, brain morphometric 
measurements in AFP were not positioned in between healthy individuals and 
SSD. Furthermore, our third study showed that neither an SVM model including 
only volumetric MRI data - nor the MRI variables included within the classifier that 
considered all the baseline variables together - demonstrated good accuracy in 
classifying SSD vs non-SSD individuals. Some studies have not found any 
differences between first-episode SSD and AFP patients, and many others do not 
include diagnostic subgroup comparisons (Arango et al., 2014). Other studies 
have however reported distinctive GM volume deficits at first episode in SSD vs 
other non-SSD GM compared to healthy controls (e.g. deficits in left medial frontal 
and left middle frontal cortex in SSD vs in left medial frontal only in bipolar 
disorder type I vs in the insula and right occipital cortex in other psychotic 
disorders [Janssen et al., 2008]). The fact that in both studies we used an ROI-
based approach might have precluded finding differences between psychosis 
diagnostic subgroups, as structural abnormalities in these disorders might 
actually be more distributed / widespread (Yu et al., 2010).  
 
In addition, a series of obstacles inherent to MRI studies have probably 
precluded drawing consistent conclusions in this regard. Firstly, both the first and 
third study included children with psychotic disorders and there are inherent 
methodological limitations to the image acquisition or processing procedures in 
youth (e.g. movement artifacts are more common) (Johnston et al., 2013). 
DISCUSSION 
100 
 
Secondly, both studies used a multicenter design. With regard to the PEPs-Img 
study (publication #1), 11 of the 16 recruiting sites participated in the 
neuroimaging module, and 196 patients and 157 controls were scanned at six 
different MRI scanner platforms, which were different in terms of manufacturer 
and field strength. For this reason, and to avoid the effects of site on the 
associations reported, a reproducibility study was conducted beforehand (see 
supplementary material 2 to publication # 1). Based on results obtained in this 
reproducibility study, all diagnostic comparative analyses (parametric and non-
parametric ones) included site as a covariate. Furthermore, results were 
presented only for those ROIs that showed reasonable reproducibility among the 
six scanners (ICCall sites ≥0.7). For those ROIs with poor reproducibility among the 
six scanners (ICCall sites <0.7) but with reasonable reproducibility between sites 1 
and 2 (ICCsites 1-2 ≥0.7), results referred only to the subsample of patients (n=131) 
and controls (n=111) scanned at these sites, as described in the Methods section. 
In the Child and Adolescent First-Episode Psychosis Study - CAFEPS 
(publication # 3), FEP patients were scanned at five different MRI scanner 
platforms, which were different in terms of manufacturer and field strength. Here 
again, a compatibility study was conducted beforehand (Reig, Sanchez-
Gonzalez, et al., 2009), showing that the inter-site coefficient of variation ranged 
from 1.8% to 5.2%, respectively, for GM and CSF volumes, whereas estimations 
of WM volume and occipital lobe volumes were more prone to site-related errors. 
In this particular study, the SVM models we developed all considered the effect 
of site (i.e. sites 1 to 5 were included as variables of interest within the high-
dimensional database) in combination with all the imaging variables while 
removing or retaining the relevant ones. All in all, we can conclude that one 
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strength of the PEPs-Img and the CAFEPS study is that the difficulties arising 
from their multicenter design were addressed. Not only we conducted a 
reproducibility study beforehand for each study, and concluded that we needed 
to include site as a covariate, but also used the results of these reproducibility 
studies to disregard some comparisons between groups in specific regions where 
the reproducibility was poor. However, even with the analyses controlling for site 
and despite the reproducibility studies conducted beforehand, it is difficult to 
argue that the effect of site was fully controlled for, meaning that in both cases 
results need to be interpreted with caution.  
 
Differences in brain structure in patients with SSD and AFP could also be 
partially accounted for by differential clinical profiles in terms of symptom 
presentation and severity (DeLisi, Sakuma, Ge, & Kushner, 1998; Nery et al., 
2009; Padmanabhan et al., 2015; Strakowski et al., 2002). In the PEPs-Img study 
(publication # 1), SSD patients and younger patients had greater symptom 
severity at baseline, which warrants caution when interpreting the results. That 
said, no significant correlations were found between symptom 
presentation/severity measures at baseline and any of the morphometric 
measurements under study, except for a negative correlation between both 
PANSS total and positive scores, and caudal middle frontal gyrus GM volume. 
This was acknowledged as a limitation to the manuscript. Similarly, both 
antipsychotics – more prescribed in the SSD group (Lesh et al., 2015; Radua et 
al., 2012) and lithium – more prescribed in the AFP / non-SSD group (Hafeman, 
Chang, Garrett, Sanders, & Phillips, 2012; Ho, Andreasen, Ziebell, Pierson, & 
Magnotta, 2011) have been reported to be potential confounders of the brain 
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abnormalities reported for FEP patients. However, both the PEPs-Img 
(publication # 1) and the CAFEPS (publication # 3) study included patients in the 
early stages of the illness (i.e. FEP patients), which made samples more 
homogenous and reduced the effect of factors such as chronicity or the effect of 
pharmacological treatments (N. C. Andreasen et al., 2013; Navari & Dazzan, 
2009; Tomelleri et al., 2009). Treatment duration was indeed relatively short in 
these samples so we deem it unlikely that medication intake biased our results. 
The careful patient-control matching strategy in both the CAFEPS and the PEPs-
Img study, the inclusion of sex and intelligence quotient (IQ) as covariates in the 
analyses of the PEPs-Img study, and the use of an SVM model in the CAFEPS 
study also helped in the handling of other relevant confounders. 
 
The above being said, both the first and third study present an advance in the 
study of the physiopathology of schizophrenia / psychotic disorders, as they are 
in keeping with the RDoC initiative. Indeed, both studies included samples of 
patients with different DSM-IV-TR diagnostic labels within the ‘psychotic disorder’ 
group. Of note, the main aim of the first study was to determine whether age at 
first episode has an effect on the diagnosis-related structural abnormalities 
detected in FEP. Similarly, the main aim of the third study was not to use MRI as 
a diagnostic tool at FEP but as a tool to inform prediction of particular diagnostic 
outcomes within the psychosis umbrella. Findings derived from this third study 
reinforce the idea that clinical prediction in psychiatry (including prediction of 
diagnosis) requires a combination of multiple measurements from different 
sources, especially in complex disorders (Sperling & Johnson, 2013). Although 
we were studying predictors of diagnostic outcomes in quite a heterogeneous 
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sample of psychosis patients, following the RDoC initiative, one of the main 
limitations of this study was that the clinical variables that were included in the 
classifier (i) conformed to a DSM-IV-TR diagnosis, and (ii) outnumbered the other 
types of variables, so it is not that striking that clinical variables were the most 
predictive within the classifier. It would have been interesting to use other 
classification methods different from SVM and coming from the machine learning 
perspective to ascertain the predictive value of all variables in general, and of 
MRI volumetric variables in particular. Along these lines, ‘non-supervised’ 
classification methods (e.g. cluster analysis or non-supervised neural networks) 
that automatically discovers regularities in the data and classifies individual into 
different but not predefined – i.e. unknown – diagnostic categories (Vapnik, 1998) 
could be of special interest. As opposed to ‘supervised’ classification methods 
(e.g. SVMs), where outputs are a priori known categories (as was the case in our 
study - SSD vs non-SSD individuals), ‘non-supervised’ classification techniques 
do not use any a priori information regarding the existence of classes between 
objects (Cochocki & Unbehauen, 1993). 
 
Another interesting approach would have been to group FEP patients by a 
range of other relevant outcomes (transdiagnostically), including functional 
outcomes, response to antipsychotic treatment or illness course (relapsing, 
number of admissions, etc.), among others. The identification of children and 
adolescents with early-onset psychosis who go on to develop poor outcomes 
should be a research priority (Díaz-Caneja et al., 2015; Parellada et al., 2015).  
Models that stratify patients according to their risk of poor outcome could help 
determine whether more intensive interventions (e.g. earlier initiation of clozapine 
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treatment or more intensive psychosocial support) are justified for a defined 
subset of these patients, which would in turn improve quality of life in this group 
and reduce the burden of disease and cost to national health systems (Díaz-
Caneja et al., 2015).  For example, it might be the case that a poorer outcome is 
associated with the presence of premorbid impairments, the presence of 
comorbid developmental conditions, higher severity of negative symptoms, or 
brain volumetric deficits transdiagnostically rather than with a categorical 
diagnosis of SSD or non-SSD (Díaz-Caneja et al., 2015; Parellada et al., 2015).  
Along these lines, SVMs could prove promising in the search for sensitive and 
specific biomarkers across psychotic disorders, and from there, they might (i) 
assist clinicians in the process of differential diagnosis, treatment choice or in 
supporting prognostic statements at early stages of psychosis, and (ii) help refine 
current diagnostic classification systems in keeping with the RDoC initiative. Until 
then, it seems that current psychosis classification systems should continue to be 
based on traditional nosology for the purpose of clinical work, while the research 
on the underlying biological mechanisms should explore the use of this 
transdiagnostic approach (e.g. across psychotic disorders). 
 
 Results from the systematic review of fMRI and DTI studies on ASD 
(publication # 2) are in keeping with the latest idea and do also provide evidence 
of blurred boundaries among different neurodevelopmental disorders. The main 
changes in the DSM-5 relative to the DSM-IV-TR in regard to ASD are (i) the term 
PDD has been changed to ASD and this category is now included in a general 
chapter of ‘neurodevelopmental disorders’, (ii) the classic symptom triad of DSM-
IV-TR (impaired social interaction, impaired communication, and presence of 
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restricted interests and activities) is now changed to the dyad ‘social 
communication’ (which lumps together ‘social interaction’ and ‘communication 
difficulties’) and ‘restricted interest / repetitive behaviour’ domains; (iii) in relation 
to the second change, there is also a new ‘social communication disorder’ 
category in which the social-communication element of the dyad is present but 
the restricted interest / repetitive behaviour is not; (iv)  there is an inclusion of 
various clinical specifiers; (v) the previous categories for autism, PDD - not 
otherwise specified (PDD-NOS), child disintegrative disorder (CDD), and 
Asperger’s Syndrome are subsumed within this new ASD category (American 
Psychiatric Association, 2013).  
 
 The DSM-5 was supposed to be a more ‘research-based’ / 
physiopathology-based classification. But do neuroimaging findings to date 
support all these changes?  With regard to the first change, we can argue that 
the finding of early brain overgrowth (i.e. in early childhood) (Courchesne et al., 
2011; Stanfield et al., 2008), increased local gyrification in adolescence (Wallace 
et al., 2013), abnormal patterns of structural and functional connectivity from an 
early age (Pina-Camacho et al., 2012), or a combination of both abnormal 
patterns of gyrification and connectivity (Bos et al., 2015) support the inclusion of 
the new ASD category in the general chapter of neurodevelopmental disorders.  
 
 With regard to the ‘symptom dyad’ change (i.e. second change), 
publication # 2 of this doctoral dissertation showed that fMRI and DTI studies 
provided support for separate neuroanatomical substrates for the social 
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communication and the behavioural symptom domains, the former being more 
related to abnormal functional and structural connectivity within fronto-temporal 
and limbic networks, whereas the latter was related to fronto-striato-cerebellar 
network deficits. These findings would be also in keeping with the third DSM-5 
change regarding the creation of a new social communication disorder. However, 
we also found that the available neuroimaging data only partially support the 
collapse of the classical social and language symptom domains into a single 
‘social communication’ domain (both for the ASD and social-communication 
category). In the DSM-IV-TR, syntactic and pragmatic language impairments 
were mixed up in the second set of criteria within the triad (‘qualitative 
impairments in communication’). Data from our review support the idea that 
syntactic language impairment and pragmatic language impairment should be 
considered separately, with the former being associated with temporo-parieto-
occipital network deficits and the latter being associated with the same abnormal 
connectivity patterns that underlie social cognition deficits (i.e. deficits in fronto-
temporal and limbic networks). Therefore, our data are congruent with the DSM-
5 inclusion of syntactic language impairment as an independent clinical specifier 
(i.e. fourth change), but they also support semantic-pragmatic language 
impairments being merged with social communication deficits. Therefore, we 
suggested at the time that it would be reasonable to include an explicit mention 
of pragmatic language deficits within the DSM-5 ‘social communication’ cluster. 
 
Findings derived from this second study are of particular relevance given 
that if different behaviours / deficits that are currently lumped together have 
different neurobiological underpinnings, or behaviours / deficits that are currently 
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not merged together have shared neurobiological underpinnings, this would have 
substantial implications for clinical management and treatment development. 
Indeed, exploring the biological underpinnings to the different symptom clusters / 
domains may help refine current diagnostic classification systems and inform 
future research on specific and effective treatments for these patients. 
 
To answer the question of whether neuroimaging data support the idea of 
subsuming previous DSM-IV-TR categories under the new ASD category (i.e. the 
fifth proposed change), we conducted an additional systematic review of 285 
structural MRI studies published between January 1990 and February 2012 and 
including patients with the different DSM-IV-TR diagnosis of PDD and healthy 
controls to assess whether they were distinguishable in terms of volumetric 
abnormalities (Pina-Camacho et al., 2013). This review concluded that there 
were not enough arguments from MRI data for or against subsuming DSM-IV-TR 
categories under a single ASD category. This was due to the fact that one group 
of studies posited that Asperger’s syndrome, high-functioning and low-functioning 
autistic disorder (HFA and LFA) were ‘quantitatively different’ diagnostic 
categories and that volumetric abnormalities should be positioned within a 
spectrum of abnormality from LFA to HFA to Asperger´s syndrome to healthy 
control brains; conversely, another group of studies supported the claim that all 
DSM-IV-TR categories were ‘qualitatively different’ diagnostic entities with 
specific brain structural abnormalities (Pina-Camacho et al., 2013). In 2000, Fred 
Volkmar argued that the inclusion of a specific diagnosis within a diagnostic 
classification system, such as Asperger´s syndrome, should be made ‘only if the 
use of the concept could be supported on the basis of some external validating 
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factor’’ (Volkmar, Klin, Schultz, Rubin, & Bronen, 2000). Before the DSM-5 
release, some authors argued that Asperger´s syndrome should be maintained 
in this classification system as a distinct entity on the basis of its distinctive clinical 
features as compared to other types of ASD (Ghaziuddin, 2010). For example, 
patients with Asperger´s syndrome usually present with an ego-dystonic lack of 
reciprocal social interaction which may in turn increase the risk for emotional 
comorbidities such as depression (Ghaziuddin, Weidmer-Mikhail, & Ghaziuddin, 
1998; Strang et al., 2012), which has a higher prevalence in patients with this 
syndrome. Authors were claiming that this ego-dystonia at least be considered a 
clinical specifier, as it could be relevant for prognosis and for treatment plan 
designing. However, if we rely on structural MRI findings, the available data do 
not help resolve the controversy about whether or not DSM-IV-TR categories 
should be subsumed under the ASD definition.  
 
There might be several reasons why we cannot resolve this controversy. 
Firstly, due to the scarcity, inconsistency, and aforementioned methodological 
limitations of MRI and fMRI studies. Secondly, because the relationship between 
structural findings and brain function is far from clear and partially complete at the 
most, and the meaning of the volume or thickness deficits at a neuropathological 
level remains unclear. Further levels of analysis progressing from measures of 
brain function to structure and downwards to the cellular, molecular and genetic 
factors that ultimately influence such function are warranted. Along these lines, 
studies integrating multiple research modalities (e.g. imaging genetics, the 
combination of MRI and magnetoencephalography or neuropathology designs, 
etc.) may help address these unanswered questions and controversies.  
DISCUSSION 
109 
 
 
Finally, we should note that neurodevelopmental conditions such as 
schizophrenia and ASD share symptomatic / psychopathological manifestations 
and neurocognitive deficits in a ‘transdiagnostic’ manner, making it difficult in 
many cases to differentiate thereof, especially in those cases with an earlier onset 
form of the disease. The main commonalities / overlaps in clinical features, social 
cognition and neuropsychological deficits are described in Annex IIa. These 
overlaps present a challenge in clinical practice to the distinction between 
schizophrenia / psychotic disorders and ASD in a significant number of cases. 
This may, to some extent, explain the main controversies surrounding the 
categorization of these disorders throughout the history of psychiatry. Even 
though both categories were separated in 1980 on the basis of the two disorders 
showing unique characteristics with different symptom profiles and course of 
illness (Rutter, 1972), the ‘broadening’ in the diagnostic criteria for autism in the 
last three decades has led to further discussions of the boundaries of both 
conditions. In parallel, the idea of psychosis / schizophrenia being part of the 
larger group of neurodevelopmental disorders (Murray & Lewis, 1987; 
Weinberger, 1986) has once again brought forth the discussion of schizophrenia 
and autism having a variety of overlapping features and of the possibility of these 
disorders representing final pathways for common causal factors and 
pathophysiological processes (Watkins, Asarnow, & Tanguay, 1988).  
 
Findings on schizophrenia and autism genetic and neuroimaging research 
fields reinforced this idea of shared pathophysiological underpinnings in both 
disorders (see Annex IIb). However, the clinical heterogeneity of ASD and 
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psychotic disorders, and the scarcity of studies to date assessing transdiagnostic 
aspects in people with such diseases has precluded progress in the 
understanding of their possible pathophysiological and etiological overlap. This 
has resulted, in turn, in the absence of objective criteria for the diagnosis of these 
disorders. In keeping with the RDoC initiative, it would therefore make sense to 
study whether complex psychiatric disorders of neurodevelopmental origin with 
common clinical / cognitive deficits in behavioural domains, show common and / 
or distinct underlying physiopathological processes and thus biological 
underpinnings. The joint study of both conditions may help revisit and improve 
the understanding of relationship and inform more effective management 
strategies. Indeed, emerging evidence points towards some promising 
psychological and pharmacological interventions which may be useful in both 
ASD and psychotic disorders, since they aim at tackling symptoms which are 
present transdiagnostically, such as social and communication impairments or 
negative symptoms.  
 
In keeping with this approach, our group our group has been interested in 
studying the overlap between ASD and psychosis in the last 10 years and is 
participating now in a multi-center European project which uses an integrative 
approach to schizophrenia / psychotic disorders and ASD, entitled ‘From autism 
to schizophrenia’ which aims at studying the genetic mechanisms underlying 
common and distinct brain functional and structural phenotypes in both disorders, 
funded by the ERA-NET NEURON (Call for transnational research projects 
2010). As part of the study of the overlap, we were particularly interested in the 
fact that both groups of patients present, as previously mentioned, with difficulties 
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in social cognition, in integrating information from the external and internal world 
and in the perception / understanding of self (e.g. self-awareness) and others, 
resulting in a limited ability to interpret (or understand) reality and themselves, 
and to generate appropriate responses to external demands (Addington & 
Rapoport, 2009; Bolte & Poustka, 2003; Couture et al., 2010; Crespi, Stead, & 
Elliot, 2010; Pinkham, Hopfinger, Pelphrey, Piven, & Penn, 2008; J. Rapoport, 
Chavez, Greenstein, Addington, & Gogtay, 2009; Roberts & Penn, 2013; 
Sugranyes, Kyriakopoulos, Corrigall, Taylor, & Frangou, 2011).  
 
It is unclear whether this shared clinical phenotype is related to a common 
neuroanatomical substrate but recent evidence suggests the insular cortex is a 
key region for these social cognitive functions (Craig, 2009; Moran et al., 2014; 
Nieuwenhuys, 2012). Indeed, a recent meta-analysis of VBM studies showed that 
a reduction of (largely anterior) insular volume was associated with different 
psychotic and non-psychotic psychiatric diagnoses (Goodkind et al., 2015). This 
meta-analysis did not include ASD, disorders in which social cognition difficulties 
are not only core but defining. Convincing evidence for a shared structural 
abnormality in the insular cortex in ASD and psychotic disorders can be obtained 
through a direct comparison of patients with these conditions (Cheung et al., 
2010; Pinkham et al., 2008; Radeloff et al., 2014; Sugranyes et al., 2011; Toal et 
al., 2009), but these studies have a great deal of limitations. We therefore set up 
a study to test whether individuals with ASD and psychotic disorders (the hallmark 
group of disorders with deficits in interpreting and understanding oneself and 
reality) shared this common neural substrate - i.e. insular pathology.  
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In this ongoing study we are using an VBM approach to analyze whole and 
regional (i.e. anterior and posterior) insular volume and thickness in a sample of 
30 children and adolescents with ASD and no mental retardation per DSM-IV-TR 
criteria (American Psychiatric Association, 2000), 29 with FEP and 26 healthy 
controls, matched for age, handedness and socioeconomic status. We want to 
evaluate, firstly, whether both patient groups show insular volume and thickness 
abnormalities (globally, and in the anterior and posterior sub-regions) with 
respect to healthy controls, and secondly, whether both patient groups share an 
insular volumetric / thickness deficit at the voxel-level areas. Our hypothesis is 
that both patient groups will show overlapping insular deficits and that these 
deficits will be associated with the severity of symptoms (e.g. socio-
communication deficits, insight deficits).  
 
Findings derived from this study seem promising and support the idea that 
a transdiagnostic approach is key to capturing fundamental underlying 
mechanisms of brain dysfunction, an approach that is central to the RDoC project 
(T. Insel et al., 2010). Further studies lumping together different psychiatric 
conditions are needed in order to understand their overlapping / distinct brain 
pathology. These might help gain new fundamental insights into the 
pathophysiology of these complex conditions but also impact disease 
management as they raise the possibility that interventions that target the 
commonly affected brain regions/networks may prove helpful across 
psychopathology. 
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This doctoral dissertation is fully engaged with the ‘science of the brain’ 
(Bullmore, Fletcher, & Jones, 2009) and demonstrates that MRI techniques can 
help psychiatrists advance in the understanding of the physiopathology of two of 
the hallmark ‘disorders of the mind’, ASD and schizophrenia / psychotic disorders. 
The main conclusions drawn from this doctoral dissertation can be found in the 
following section (see section 7. Conclusions). 
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7. CONCLUSIONS 
 
1. Diagnosis-related volume and thickness abnormalities in patients with 
psychotic disorders are dependent on age at FEP, and are present in brain 
regions undergoing maturation at each particular developmental stage. 
 
2. Age at first episode has a non-linear effect on the diagnosis-related 
structural abnormalities detected in FEP.  
 
3. The DSM-5 proposal of a symptom dyad in ASD is only partially supported 
by fMRI and DTI data. A shared neuroanatomical substrate for social and 
pragmatic language deficits suggests that it would be reasonable to 
include an explicit mention of pragmatic language deficits within the ‘social 
communication’ cluster. 
 
4. Combined clinical and cognitive data but not volumetric MRI data can 
accurately predict a diagnostic outcome of SSD in patients with early-
onset FEP. 
 
5. MRI techniques are helpful tools for gaining insight into the 
physiopathology of ASD and psychotic disorders.  
 
6. Although it is reasonable that diagnostic classification systems in 
psychiatry continue to be based on traditional nosology for the purpose of 
clinical work, research on the underlying biological mechanisms may 
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require the use of transdiagnostic or even phenomenon-based 
approaches, in line with the RDoC initiative.
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8. SUMMARY 
 
“APPLICATION OF MAGNETIC RESONANCE IMAGING TO THE STUDY OF 
AUTISM SPECTRUM DISORDERS AND PSYCHOTIC DISORDERS” 
 
8.1. INTRODUCTION 
 
Among psychiatric disorders, there is a group of conditions that seem to 
emerge from perturbations of normal brain maturation at early stages of 
development, collectively known as neurodevelopmental disorders. Indeed, the 
new Diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) 
classification system includes a new chapter entitled ‘Neurodevelopmental 
Disorders’, which includes – among others - the autism spectrum disorders (ASD) 
(American Psychiatric Association, 2013). Although schizophrenia and other 
psychotic disorders do not fall into this chapter, a neurodevelopmental 
pathophysiology of these conditions has been proposed (Murray & Lewis, 1987; 
Weinberger, 1986), as patients show delays in signs of early neurodevelopment 
during childhood and adolescence before the emergence of the first psychotic 
episode (McGorry et al., 2006), which usually occurs around late adolescence / 
young adulthood (Kessler et al., 2005; Paus et al., 2008).  
 
With the advances in neuroscience and particularly in neuroimaging, 
psychiatrists can further the understanding of the complex origins and 
physiopathology of these two highly prevalent and debilitating 
neurodevelopmental conditions. Specifically, magnetic resonance imaging (MRI) 
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techniques can help achieve this goal through the study of both the normally 
developing brain and of the structural and functional brain abnormalities present 
in the affected individuals. Indeed, despite the scarcity and numerous 
methodological limitations of MRI studies, and although the relationship between 
structural findings / brain function / symptoms is far from clear, the advent of MRI 
techniques has shed some light on the pathogenesis / physiopathology of these 
neurodevelopmental conditions. For example, there are some consistent 
disease-specific findings derived from MRI studies, including (i) the increased 
volume of the ventricular system or the - less consistently reported - decreased 
volume of prefrontal lobe in brains of patients with first-episode schizophrenia 
relative to controls (El-Sayed et al., 2010; Farrow, Whitford, Williams, Gomes, & 
Harris, 2005; Janssen et al., 2012; Janssen et al., 2014; Narr et al., 2005; Radua 
et al., 2012; Voets et al., 2008); (ii) the progression of these brain structural 
changes over the first years of the illness in these patients (Fusar-Poli et al., 2013; 
Haijma et al., 2013; Olabi et al., 2011; Vita, De Peri, Deste, & Sacchetti, 2012; 
Gogtay, Sporn, et al., 2004; James, James, Smith, & Javaloyes, 2004; Arango et 
al., 2012; Reig, Moreno, et al., 2009; Fraguas, Diaz-Caneja, Pina-Camacho, 
Janssen, & Arango, 2014); or (iii) the early brain overgrowth observed in early 
childhood in patients with ASD (Courchesne, Campbell, & Solso, 2011; Stanfield 
et al., 2008). 
 
However, there is still a number of unanswered questions in relation to the 
pathophysiology of these conditions. For example, it is unclear if and how age at 
onset influences the structural abnormalities found in patients with first episodes 
of psychosis (FEP). It is also unclear whether MRI findings support symptom 
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grouping within diagnostic categories in current classification systems such as 
the DSM-5. Finally, the value of MRI data as a tool to inform prediction / 
prognostic statements in clinical settings is largely unexplored. 
 
By gaining further insight into the pathophysiology of ASD and psychotic 
disorders, diagnostic classification systems in psychiatry could be refined, as 
diagnostic categories are still based solely on the observation of symptoms and 
behaviours with a limited psychopathological rigor and understanding of the 
underlying pathophysiology (American Psychiatric Association, 2013; World 
Health Organisation, 1992), In 2010, the National Institute of Mental Health 
(NIMH) of the United States underscored the potential advantages of a 
neuroscience-based approach to psychiatric classification  (T. Insel et al., 2010). 
The Research Domain Criteria (RDoC) initiative was then launched with the main 
goal of ensuring that psychiatric diagnoses had not only reliability but also validity. 
The NIMH suggested that this could be achieved by creating a framework for 
research on pathophysiology, especially for genomics and neuroimaging, which 
ultimately will inform future classification schemes (T. Insel et al., 2010). In 
keeping with this initiative, this doctoral dissertation will focus on two 
neurodevelopmental conditions, ASD and psychotic disorders, and on the 
application of MRI (i) to the study of their complex origins and physiopathology, 
and (ii) as a tool be applied in clinical settings to inform prediction statements and 
clinical management. 
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8.2. OBJECTIVES 
 
This thesis investigates how structural MRI, functional MRI (fMRI) and 
diffusion tensor imaging (DTI) techniques may be used to advance in the 
understanding of the physiopathology of two of the hallmark neurodevelopmental 
disorders, ASD and psychotic disorders. Specifically, it addresses three 
unanswered questions in this regard: (i) Does age at first psychotic episode have 
a non-linear effect on the diagnosis-related structural abnormalities detected in 
patients experiencing a first episode of psychosis (FEP)? (ii) Do results from fMRI 
and DTI studies support the ASD symptom grouping / clustering proposed by the 
new DSM-5 classification system? and (iii) Do volumetric MRI data help predict 
a diagnostic outcome of SSD in early-onset FEP patients? 
 
 
8.3. HYPOTHESES 
 
We hypothesized that (i) in patients with psychosis, diagnostic-related 
volume and thickness abnormalities are dependent on the age at first episode, 
(ii) the dependency of structural abnormalities on age at first episode follows a 
non-linear curve, (iii) in patients with ASD, social and communication deficits are 
associated with shared abnormalities in functional and structural connectivity in 
the same brain regions / networks, so they can be collapsed into a single 
symptom domain, (iv) the affected networks are different to those associated with 
the presence of repetitive behaviours and restricted interests, and (v) combined 
clinical, cognitive and volumetric MRI data can accurately predict a diagnostic 
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outcome of schizophrenia spectrum disorder (SSD) in patients with early-onset 
FEP. 
 
 
8.4. METHODS 
 
Two original articles and one systematic review authored by the doctoral 
student are included in this thesis dissertation. 
 
Pina-Camacho L., Del Rey-Mejias A., Janssen J., Bioque M., González-Pinto A.,  
Arango C., Lobo A., Sarró S., Desco M., Sanjuan J., Lacalle-Aurioles M., Cuesta 
MJ., Saiz-Ruiz J., Bernardo M., Parellada M., and the PEPs group. Age at First 
Episode Modulates Diagnosis-Related Structural Brain Abnormalities in 
Psychosis. Schizophrenia Bulletin (in press), doi:10.1093/schbul/sbv128. 
Original study.  
 
This was a multicenter cross-sectional case-controlled brain MRI study. Patients 
with FEP (n = 196), 65.3% males, with a wide age range at FEP onset (12-35 
years), and healthy controls (n = 157), matched for age, sex, and handedness, 
were scanned at six sites. Gray matter (GM) volume and thickness 
measurements were generated for several brain regions using FreeSurfer 
software. The non-linear relationship between age at scan (a proxy for age at 
FEP in patients) and volume and thickness measurements was explored in 
patients with SSD, affective psychoses (AFP), and healthy controls. 
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Pina-Camacho L., Villero S.,  Fraguas D., Boada L., Janssen J., Navas-Sánchez 
FJ., Mayoral M., Llorente C., Arango C., Parellada M. Autism Spectrum Disorder: 
Does neuroimaging support the DSM-5 proposal for a symptom dyad? A 
systematic review of functional magnetic resonance imaging and diffusion tensor 
imaging studies. Journal of Autism and Developmental Disorders 42(7):1326-41, 
2012. Systematic review. 
 
A systematic Medline/Pubmed review of 208 studies published in English 
between January 1990 and April 2011 and comprising fMRI and DTI imaging data 
in patients with ASD was conducted. Studies were classified according to the 
neuroimaging technique used as follows: (a) fMRI studies using tasks related to 
social cognition and interaction, (b) fMRI studies using language-related tasks, 
(c) fMRI studies using tasks related to repetitive behaviours or restricted interests, 
(d) studies using ‘fMRI at resting state,’ and (e) studies using a DTI technique. 
Within each fMRI study, we extracted the information about the affected regions 
in patients with ASD compared with healthy controls, in terms of abnormal 
activation of particular brain regions or abnormal functional connectivity. For DTI 
studies, we looked at affected regions and networks in patients with ASD 
compared with controls in terms of abnormal structural integrity of white matter 
(WM) tracts. 
 
Pina-Camacho L., García-Prieto J., Parellada M., Castro-Fornieles J., Gonzalez-
Pinto AM., Bombin I., Graell M., Paya B., Rapado-Castro M., Janssen J., Baeza 
I., Del Pozo F., Desco M., Arango C. Predictors of Schizophrenia Spectrum 
Disorders in Early-onset First Episodes of Psychosis: A Support Vector Machine 
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Model. European Child and Adolescent Psychiatry 24:427–440, 2015. Original 
study. 
 
Data were gathered from a 2-year, prospective, longitudinal study of 81 patients 
(age 9–17 years) with early-onset FEP and a stable diagnosis during follow-up 
and 42 age- and sex-matched healthy controls. The input was different 
combinations of baseline clinical, neuropsychological, MRI brain volumetric and 
biochemical data, and the output was the diagnosis at follow-up (SSD vs. non-
SSD, SSD vs. control, and non-SSD vs. control). Several support vector machine 
(SVM) classifiers were developed and enhanced recursive feature elimination 
was performed to select and rank the input variables with the highest predictive 
value for a diagnostic outcome of SSD. Classifiers were validated using leave 
one out cross-validation, jackknifing, and an independent test set. 
 
 
8.5. RESULTS 
 
Results from the first study indicate that (i) diagnosis-related volume / 
thickness abnormalities in patients with FEP are mainly present in brain regions 
undergoing maturation at each particular developmental stage, and (ii) age at first 
episode modulates these abnormalities in a nonlinear manner. 
 
The second study supports (i) the presence of separate neuroanatomical 
substrates for the ‘social communication’ and ‘repetitive behavior / restricted 
interest’ symptom domains that comprise the DSM-5 diagnostic dyad for ASD, (ii) 
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the presence of separate neuroanatomical substrates for syntactic and pragmatic 
language impairments, and (iii) the presence of a shared neuroanatomical 
substrate for social and pragmatic language deficits. 
 
In the third study we show that (i) an SVM model containing a combination 
of clinical and neuropsychological variables has the highest predictive value for 
a diagnostic outcome of SSD in patients with early-onset FEP, and (ii) that MRI 
volumetric data do not add to the predictive value. 
 
 
8.6. DISCUSSION 
 
The studies that are part of this doctoral dissertation present an advance 
in the study of the physiopathology of two of the hallmark neurodevelopmental 
disorders, schizophrenia / psychotic disorders and ASD, through the use of MRI 
techniques.  
 
Results from the first study are in keeping with the neurodevelopmental 
model of schizophrenia / psychotic disorders, as they show an interaction 
between brain maturation events and the morphometric abnormalities detected 
in FEP. They also indicate that MRI studies in FEP should take into account the 
nonlinear effect of age on brain structure when interpreting samples with different 
age at FEP and diagnosis.  
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Findings derived from the second study are of particular relevance given 
that if different behaviours / deficits that are currently lumped together have 
different neurobiological underpinnings, or behaviours / deficits that are currently 
not merged together have shared neurobiological underpinnings, this would have 
substantial implications for clinical management and treatment development. 
Along these lines, this second study supports the creation of the new ASD dyad 
and the creation of the new social communication disorder. Similarly, the 
presence of separate neuroanatomical substrates for syntactic and pragmatic 
language impairments, is congruent with the DSM-5 inclusion of syntactic 
language impairment as an independent clinical specifier. However, the presence 
of a shared neuroanatomical substrate for social and pragmatic language deficits 
suggests that it would be reasonable to include an explicit mention of pragmatic 
language deficits within the ‘social communication’ cluster. This shows how 
exploring the biological underpinnings to the different symptom clusters / domains 
through the use of MRI techniques may help refine current diagnostic 
classification systems and inform future research on specific and effective 
treatments for these patients. 
 
Findings derived from the third study reinforce the idea that clinical 
prediction in psychiatry (including prediction of diagnosis) requires a combination 
of multiple measurements from different sources, and support that SVMs could 
prove promising in the search for sensitive and specific biomarkers across 
psychotic disorders. From there, these tools might (i) assist clinicians in the 
process of differential diagnosis, treatment choice or in supporting prognostic 
statements at early stages of psychosis, and (ii) help refine current diagnostic 
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classification systems in keeping with the RDoC initiative. Until then, it seems that 
current psychosis classification systems should continue to be based on 
traditional nosology for the purpose of clinical work, while the research on the 
underlying biological mechanisms should explore the use of this transdiagnostic 
approach (e.g. across psychotic disorders, or even across neurodevelopmental 
conditions such as ASD and psychotic disorders). 
 
In summary, the studies that are part of this doctoral dissertation 
demonstrate that we can advance in the understanding of the physiopathology of 
‘disorders of the mind’ (such as ASD and psychotic disorders) through the use of 
‘the science of the brain’ (e.g. the use of MRI techniques) (Bullmore et al., 2009). 
The main conclusions drawn from this doctoral dissertation can be found in the 
following section. 
 
 
8.7. CONCLUSIONS 
 
1. Diagnosis-related volume and thickness abnormalities in patients with 
psychotic disorders are dependent on age at FEP, and are present in brain 
regions undergoing maturation at each particular developmental stage. 
 
2. Age at first episode has a non-linear effect on the diagnosis-related 
structural abnormalities detected in FEP.  
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3. The DSM-5 proposal of a symptom dyad in ASD is only partially supported 
by fMRI and DTI data. A shared neuroanatomical substrate for social and 
pragmatic language deficits suggests that it would be reasonable to 
include an explicit mention of pragmatic language deficits within the ‘social 
communication’ cluster. 
 
4. Combined clinical and cognitive data but not volumetric MRI data can 
accurately predict a diagnostic outcome of SSD in patients with early-
onset FEP. 
 
5. MRI techniques are helpful tools for gaining insight into the 
physiopathology of ASD and psychotic disorders.  
 
6. Although it is reasonable that diagnostic classification systems in 
psychiatry continue to be based on traditional nosology for the purpose of 
clinical work, research on the underlying biological mechanisms may 
require the use of transdiagnostic or even phenomenon-based 
approaches, in line with the RDoC initiative. 
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9. RESUMEN 
 
“APLICACIÓN DE TÉCNICAS DE RESONANCIA MAGNÉTICA AL ESTUDIO 
DE LOS TRASTORNOS DEL ESPECTRO AUTISTA  
Y LOS TRASTORNOS PSICÓTICOS” 
 
9.1. INTRODUCCIÓN 
 
Entre los trastornos psiquiátricos, existe un grupo determinado de trastornos 
cuyo origen parece estar relacionado con la aparición de alteraciones en el 
proceso de maduración normal del cerebro en las primeras etapas del desarrollo, 
conocido como el grupo de los ‘trastornos del neurodesarrollo’. De hecho, el 
nuevo sistema de clasificación DSM-5 incluye un nuevo capítulo titulado 
‘Trastornos del neurodesarrollo’, que incluye - entre otros - los trastornos del 
espectro autista (TEA) (American Psychiatric Association, 2013). Aunque la 
esquizofrenia y otros trastornos psicóticos no forman parte de este capítulo, 
podrán ser entendidos como trastornos que también emergen de una alteración 
en el neurodesarrollo (Murray & Lewis, 1987; Weinberger, 1986), dado que estos 
pacientes muestran signos de retraso en el desarrollo temprano, los cuales son 
observables durante la infancia y la adolescencia previo a la aparición del primer 
episodio psicótico (McGorry et al., 2006), episodio que suele ocurrir en la 
adolescencia o etapa adulta temprana (Kessler et al., 2005; Paus et al., 2008).  
 
Gracias a los avances en el ámbito de la neurociencia y en particular en el de 
la neuroimagen, los psiquiatras podemos hoy día avanzar en el conocimiento de 
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los orígenes y la fisiopatología de ambos trastornos del neurodesarrollo, 
altamente prevalentes en la población y de elevado impacto socio-sanitario. En 
concreto, las técnicas de resonancia magnética (RM) parecen ser herramientas 
muy valiosas de cara a la consecución de dicho objetivo, a través del estudio 
tanto del cerebro normal en desarrollo como de las anomalías cerebrales 
estructurales y funcionales presentes en los individuos afectados. 
 
A pesar de la escasez de resultados consistentes y de las numerosas 
limitaciones metodológicas de los estudios de RM, y a pesar de que la relación 
entre los hallazgos de estructura, función cerebral y síntomas no está 
completamente establecida, el advenimiento de las técnicas de RM ha permitido 
arrojar algo de luz sobre la patogénesis / fisiopatología de estas enfermedades 
del neurodesarrollo. Por ejemplo, determinados hallazgos relativamente 
específicos de trastorno han sido bien replicados por estudios de RM, lo cual ha 
permitido avanzar en el conocimiento de las bases neurobiológicas de estos 
trastornos. Entre dichos hallazgos se incluyen el aumento de volumen del 
sistema ventricular o la disminución de volumen del lóbulo prefrontal (este último 
quizá menos replicado) observado en cerebros de pacientes con un primer 
episodio de esquizofrenia en comparación con controles sanos (El-Sayed et al., 
2010; Farrow, Whitford, Williams, Gomes, & Harris, 2005; Janssen et al., 2012; 
Janssen et al., 2014; Narr et al., 2005; Radua et al., 2012; Voets et al., 2008), la 
progresión de dichos cambios estructurales cerebrales en estos pacientes 
durante los primeros años de la enfermedad (Fusar-Poli et al., 2013; Haijma et 
al., 2013; Olabi et al., 2011; Vita, De Peri, Deste, & Sacchetti, 2012; Gogtay, 
Sporn, et al., 2004; James, James, Smith, & Javaloyes, 2004; Arango et al., 2012; 
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Reig, Moreno, et al., 2009; Fraguas, Diaz-Caneja, Pina-Camacho, Janssen, & 
Arango, 2014), o el crecimiento excesivo del cerebro descrito en pacientes con 
TEA en la infancia temprana (Courchesne, Campbell, & Solso, 2011; Stanfield et 
al., 2008). Sin embargo, siguen existiendo numerosas preguntas sin respuesta 
en torno a las bases neurobiológicas y la fisiopatología de estas condiciones. Por 
ejemplo, no está claro si la edad de inicio influye en las anomalías cerebrales 
estructurales detectadas en pacientes con un primer episodio de psicosis (PEP), 
y de qué manera lo hace. Tampoco está claro si los hallazgos de la RM apoyan 
las diferentes agrupaciones sintomáticas presentes en los sistemas de 
clasificación diagnóstica actuales, tales como el DSM-5. Por último, existen 
pocos datos acerca del valor de las variables obtenidas por RM como 
herramienta de ayuda en la predicción de pronóstico y manejo de los pacientes 
con trastornos del neurodesarrollo en la práctica clínica. 
 
Mediante el avance en el conocimiento de la fisiopatología de los TEA y los 
trastornos psicóticos, los sistemas actuales de clasificación diagnóstica en 
psiquiatría podrían ser perfeccionados. De hecho, las categorías diagnósticas 
actuales están únicamente basadas en la observación de síntomas y 
comportamientos, con un rigor psicopatológico limitado y una escasa 
comprensión de la fisiopatología subyacente a estas condiciones psiquiátricas 
(American Psychiatric Association, 2013; World Health Organisation, 1992). En 
2010, el Instituto Nacional de Salud Mental (NIMH) de los Estados Unidos 
rescató la idea del DSM-III según la cual existirían numerosas ventajas en la 
creación de un enfoque de clasificación psiquiátrica basado en la neurociencia 
(T. Insel et al., 2010). En este sentido, el NIMH trató de llegar a un consenso 
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sobre la manera de lograr este objetivo y puso en marcha la iniciativa Research 
Domain Criteria (RDoC), cuyo objetivo principal era asegurar que los 
diagnósticos psiquiátricos fueran no sólo fiables, sino también válidos. El NIMH 
sugirió que dicho objetivo podría lograrse mediante la creación de un marco de 
investigación de la fisiopatología de las enfermedades mentales, especialmente 
en el área de la genómica y la neuroimagen, que en última instancia ayudaría a 
diseñar los futuros esquemas de clasificación (T. Insel et al., 2010). En 
consonancia con esta iniciativa, esta tesis doctoral se centra en dos grupos de 
trastornos del neurodesarrollo, los TEA y los trastornos psicóticos, y en la 
aplicación de las técnicas de RM (i) como herramienta de estudio de sus 
orígenes complejos y fisiopatología subyacente, y (ii) como herramienta de 
ayuda en la predicción de pronóstico y manejo de los pacientes con estos 
trastornos en la práctica clínica. 
 
 
9.2. OBJETIVOS 
 
Esta tesis investiga cómo las técnicas de RM estructural (RM), RM 
funcional (fMRI) y la imagen por tensor de difusión (DTI) pueden ayudar a 
avanzar en la comprensión de la fisiopatología de dos de los trastornos claves 
del neurodesarrollo, los TEA y los trastornos psicóticos. En concreto, se abordan 
tres preguntas no contestadas hasta la fecha en relación con ambos trastornos: 
(i) en pacientes con un primer episodio de psicosis (PEP), ¿tiene la edad del 
primer episodio psicótico un efecto no lineal en las anomalías estructurales 
relacionadas con el diagnóstico? (ii) ¿Apoyan los resultados derivados de 
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estudios de fMRI y DTI en TEA la propuesta de agrupación de síntomas en una 
diada realizada por el nuevo sistema de clasificación DSM-5? (iii) En pacientes 
con un PEP de inicio temprano, ¿los datos de  volumetría cerebral obtenidos por 
RM ayudan en la predicción de un diagnóstico futuro de trastorno del espectro 
de la esquizofrenia (TESZ)? 
 
 
9.3. HIPÓTESIS 
 
Las principales hipótesis de esta tesis doctoral son las siguientes: (i) en 
pacientes con trastornos psicóticos, las alteraciones detectadas en volumen y 
grosor de corteza y relacionadas con el diagnóstico dependen de la edad del 
primer episodio psicótico, (ii) la asociación entre dichas anomalías cerebrales y 
la edad del primer episodio sigue un patrón no lineal, (iii) en pacientes con TEA, 
los déficits sociales y de comunicación están asociados con anomalías comunes 
de conectividad funcional y estructural que afectan a las mismas regiones / redes 
cerebrales, por lo que se pueden agrupar en un mismo dominio sintomático, (iv) 
dichas redes afectadas son distintas a las asociadas con la presencia de 
conductas repetitivas e intereses restringidos, y (v) una combinación de datos 
clínicos, cognitivos y volumétricos obtenidos por RM ayuda a predecir con 
exactitud un diagnóstico futuro de TESZ en pacientes con un PEP de inicio 
temprano. 
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9.4. MÉTODOS 
 
Esta tesis está compuesta por tres publicaciones: dos artículos originales y una 
revisión sistemática, todas ellas lideradas por el doctorando. 
 
Pina-Camacho L., Del Rey-Mejias A., Janssen J., Bioque M., González-Pinto A.,  
Arango C., Lobo A., Sarró S., Desco M., Sanjuan J., Lacalle-Aurioles M., Cuesta 
MJ., Saiz-Ruiz J., Bernardo M., Parellada M., and the PEPs group. Age at First 
Episode Modulates Diagnosis-Related Structural Brain Abnormalities in 
Psychosis. Schizophrenia Bulletin (in press), doi:10.1093/schbul/sbv128. Artículo 
original.  
 
Estudio trasversal y multicéntrico de RM cerebral de casos y controles. Una 
muestra de pacientes con PEP (n = 196), 65.3% varones, con una amplio rango 
de edad de inicio del PEP (12-35 años), y de controles sanos (n = 157), 
emparejados por edad, sexo y lateralidad manual fue reclutada y escaneada en 
seis centros. Se realizaron mediciones de volumen y grosor de sustancia gris 
(SG) cortical para varias regiones del cerebro empleando el software FreeSurfer. 
La relación no lineal entre la edad en el momento del escáner (un proxy de la 
edad del PEP en pacientes) y las medidas de volumen y grosor cortical fue 
analizada en pacientes con TESZ, trastornos afectivos psicóticos (TAFP) y 
controles sanos. 
 
Pina-Camacho L., Villero S.,  Fraguas D., Boada L., Janssen J., Navas-Sánchez 
FJ., Mayoral M., Llorente C., Arango C., Parellada M. Autism Spectrum Disorder: 
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Does neuroimaging support the DSM-5 proposal for a symptom dyad? A 
systematic review of functional magnetic resonance imaging and diffusion tensor 
imaging studies. Journal of Autism and Developmental Disorders 42(7):1326-41, 
2012. Revisión sistemática. 
 
Se realizó una revisión sistemática en Medline / Pubmed de 208 estudios 
publicados en Inglés entre enero de 1990 y abril de 2011 que contuviesen datos 
de fMRI y DTI de pacientes con TEA. Los estudios fueron clasificados de la 
siguiente manera, de acuerdo con la técnica de neuroimagen empleada: (a) 
estudios de fMRI que emplean tareas relacionadas con cognición social e 
interacción social, (b) estudios de fMRI que emplean tareas relacionadas con 
lenguaje, (c) estudios de fMRI que emplean tareas relacionadas con 
comportamientos repetitivos o intereses restringidos, (d) estudios de fMRI en 
‘estado de reposo’ (resting state), y (e) estudios que emplean técnicas de DTI. 
Para cada estudio de fMRI, se extrajo la información sobre las regiones 
afectadas en pacientes con TEA en comparación con controles sanos, en 
términos de activación anormal de regiones particulares del cerebro o de 
conectividad funcional alterada. Para los estudios de DTI, se extrajo la 
información sobre las regiones y redes afectadas en relación con la  integridad 
estructural de la sustancia blanca (SB)  en pacientes con TEA en comparación 
con controles. 
 
Pina-Camacho L., García-Prieto J., Parellada M., Castro-Fornieles J., Gonzalez-
Pinto AM., Bombin I., Graell M., Paya B., Rapado-Castro M., Janssen J., Baeza 
I., Del Pozo F., Desco M., Arango C. Predictors of Schizophrenia Spectrum 
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Disorders in Early-onset First Episodes of Psychosis: A Support Vector Machine 
Model. European Child and Adolescent Psychiatry 24:427–440, 2015. Artículo 
original. 
 
Los datos provienen de un estudio longitudinal, prospectivo, de 2 años de 
seguimiento de 81 pacientes (edad 9-17 años) con un PEP de inicio temprano y 
un diagnóstico estable durante el seguimiento y 42 controles sanos emparejados 
por edad y sexo. Las variables predictoras estudiadas incluían diferentes 
combinaciones de datos clínicos, neuropsicológicos, de volumétrica cerebral por 
RM y bioquímicos, y la variable a predecir era el diagnóstico en el seguimiento 
longitudinal (TESZ frente a no-TESZ, TESZ frente a control, y no-TESZ frente a 
control). Varios clasificadores tipo máquina de vectores de soporte (support 
vector machine - SVM) fueron desarrollados y una función recursiva de 
eliminación fue aplicada a cada modelo para seleccionar y clasificar las variables 
de entrada según su valor predictivo para el diagnóstico de TESZ. Los distintos 
clasificadores fueron validados mediante validación cruzada tipo leave one out 
cross-validation, jackknifing, y una submuestra de individuos independiente. 
 
 
9.5. RESULTADOS 
 
El primer estudio de esta tesis doctoral encuentra que (i) las anomalías de 
volumen / grosor cortical relacionadas con el diagnóstico en pacientes con PEP 
están presentes principalmente en aquellas regiones del cerebro que presentan 
un proceso de maduración activa en cada momento particular del desarrollo, y 
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(ii) que la edad de inicio del primer episodio modula dichas anomalías de forma 
no lineal. 
 
El segundo estudio apoya (i) la existencia de un sustrato neuroanatómico 
diferente para los dos dominios sintomáticos que conforman la diada diagnóstica 
de los TEA incluida en el DSM-5: ‘déficits sociales y de comunicación’ y 
‘comportamientos repetitivos / intereses restringidos, (ii) la existencia de un 
sustrato neuroanatómico diferente para los déficits sintácticos vs pragmáticos del 
lenguaje y (iii) la presencia de un sustrato neuroanatómico común para el 
subdominio sintomático ‘déficits en interacción / cognición social’ y los déficits 
pragmáticos del lenguaje, lo que sugiere que sería razonable incluir una mención 
explícita a este déficit pragmático del lenguaje dentro del dominio de ‘déficits 
sociales y de comunicación’. 
 
En el tercer estudio se muestra (i) que el modelo SVM que contiene una 
combinación de variables clínicas y neuropsicológicas tiene el mayor valor 
predictivo para el diagnóstico de TESZ en pacientes con un PEP inicio temprano, 
y (ii) que los datos de volumetría cerebral de RM no poseen valor predictivo por 
sí mismo ni añaden valor predictivo al mejor modelo. 
 
 
9.6. DISCUSIÓN 
 
Los estudios que forman parte de esta tesis doctoral representan un 
avance en el estudio de la fisiopatología de dos de los trastornos clave del 
RESUMEN 
144 
 
neurodesarrollo, la esquizofrenia / trastornos psicóticos y los TEA, a través del 
uso de técnicas de RM. 
 
Los resultados del primer estudio están en consonancia con la hipótesis 
del neurodesarrollo de los trastornos psicóticos / esquizofrenia, ya que muestran 
que existe una interacción entre los eventos de maduración del cerebro en 
desarrollo y las anomalías morfométricas detectadas durante el PEP. Estos 
resultados también indican que los estudios de RM en PEP deberían siempre 
tener en cuenta el efecto no lineal de la edad en la estructura del cerebro, en 
especial si incluyen muestras con diferentes edades de inicio del PEP y 
diagnóstico.  
 
Los resultados derivados del segundo estudio son de especial relevancia 
dado que si diferentes síntomas / déficits que se agrupan actualmente bajo un 
mismo dominio tienen diferentes bases neurobiológicas, o, del otro modo, 
síntomas / déficits que actualmente no se consideran juntos comparten bases 
neurobiológicas, esto tendría implicaciones muy importantes en cuanto a manejo 
clínico de los pacientes y desarrollo de nuevos tratamientos. En este sentido, 
este segundo estudio apoya la creación de la nueva diada diagnóstica y de la 
nueva categoría trastorno de  ‘déficits sociales y de comunicación’ Asimismo, la 
existencia de un sustrato neuroanatómico diferente para los déficits sintácticos 
vs pragmáticos del lenguaje es congruente con la inclusión en el DSM-5 de los 
déficits sintácticos del lenguaje como especificador clínico independiente. Sin 
embargo, la presencia de un sustrato neuroanatómico común para el subdominio 
sintomático ‘déficits en interacción / cognición social’ y los déficits pragmáticos 
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del lenguaje sugiere que sería razonable incluir una mención explícita a este 
déficit pragmático del lenguaje dentro del dominio de ‘déficits sociales y de 
comunicación’. Este segundo estudio muestra por tanto cómo el conocimiento 
de las bases biológicas de los diferentes grupos de síntomas / dominios a través 
de técnicas de RM puede ayudar en el perfeccionamiento y mejora de los 
sistemas de clasificación diagnóstica actuales y servir de base para futuras 
investigaciones en líneas de tratamientos específicas y eficaces para estos 
pacientes. 
 
Los resultados derivados del tercer estudio refuerzan la idea de que la 
predicción clínica en psiquiatría (incluyendo la predicción del diagnóstico) 
requiere una combinación de múltiples datos / medidas provenientes de múltiples  
fuentes, y apoyan la teoría de que las SVMs podrían ser herramienta 
prometedoras para la búsqueda de biomarcadores sensibles y específicos en los 
diferentes trastornos psicóticos. Partiendo de esa base, estas herramientas 
permitirían (i) ayudar a los clínicos en el proceso de diagnóstico diferencial, 
elección del tratamiento o información a pacientes y familiares sobre el 
pronóstico en las primeras etapas de la psicosis, y (ii) ayudar a perfeccionar los 
sistemas de clasificación de diagnóstico actuales de acuerdo con la iniciativa 
RDoC. Hasta entonces, parece que los sistemas de clasificación actuales 
tendrán que seguir basándose en la nosología tradicional con fines clínicos y de 
manejo. Sin embargo, la investigación sobre los mecanismos biológicos 
subyacentes a los trastornos psiquiátricos debería emplear un enfoque 
transdiagnóstico (por ejemplo estudiando muestras de pacientes con diferentes 
trastornos psicóticos, o incluso pacientes con diferentes trastornos del 
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neurodesarrollo, tales como los TEA y los trastornos psicóticos de forma 
conjunta) de cara a ayudar al diseño de sistemas de clasificación no sólo fiables 
sino también válidos. 
 
En resumen, los estudios que forman parte de esta tesis doctoral 
demuestran que las técnicas de RM pueden ayudar a avanzar en el conocimiento 
de la fisiopatología de dos ‘trastornos de la mente’ por excelencia (los TEA y los 
trastornos psicóticos), a través del uso de la ‘ciencia del cerebro’ o neurociencia 
(ej. a través del uso de técnicas de RM) (Bullmore et al., 2009). Las conclusiones 
de esta tesis doctoral se resumen en la siguiente sección. 
 
 
9.7. CONCLUSIONES 
 
1.  En pacientes con un PEP, las alteraciones de volumen y grosor de 
corteza relacionadas con el diagnóstico dependen de la edad de inicio de 
dicho primer episodio, y están presentes en aquellas regiones del cerebro 
que presentan un proceso de maduración activa en cada momento 
particular del desarrollo. 
 
2. En pacientes con un PEP, la edad del primer episodio tiene un efecto no 
lineal en las anomalías cerebrales estructurales relacionadas con el 
diagnóstico. 
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3. La nueva propuesta de diada sintomática de los TEA realizada por el 
DSM-5 es sustentada por datos de estudios de fMRI y DTI, pero sólo de 
manera parcial. La presencia de un sustrato neuroanatómico común para 
el subdominio  sintomático ‘déficits en interacción / cognición social’ y los 
déficits pragmáticos del lenguaje sugiere que sería razonable incluir una 
mención explícita a este déficit pragmático del lenguaje dentro del nuevo 
dominio de ‘déficits sociales y de comunicación’. 
 
4. En pacientes con un PEP de inicio temprano, una combinación de datos 
clínicos, cognitivos, pero no de volumetría cerebral por RM predice con 
exactitud un diagnóstico futuro de TESZ. 
 
5. Las técnicas de RM son herramientas prometedoras para avanzar en el 
conocimiento de la fisiopatología de los TEA y los trastornos psicóticos. 
 
6. Aunque parece razonable que los sistemas de clasificación diagnóstica 
en psiquiatría sigan basándose en la nosología tradicional para su uso en 
la práctica clínica, la investigación sobre los mecanismos biológicos 
subyacentes a los trastornos psiquiátricos debería emplear un enfoque 
transdiagnóstico, en la línea del proyecto RDoC. Esto ayudaría a diseñar 
en el futuro sistemas de clasificación no sólo fiables, sino también válidos. 
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11. ANNEXES 
 
Annex I. Is prevalence of ASD increasing? 
 
Since the release of last figure by the US Centers for Disease Control and 
Prevention (CDC), in which 1 in every 110 children is affected of ASD (Baxter et 
al., 2014; Weintraub, 2011), there has been ongoing debate over whether the 
prevalence of this disorder is indeed increasing (see Annex 1 – Figure 1). 
 
Annex 1 – Figure 1. Raise in autism diagnoses since the 1970s 
 
 
From (Weintraub, 2011). Permission for reprint granted by Nature Publishing Group through 
Copyright Clearance Center (‘CCC’). 
 
 
This phenomenon is probably due to a combination of different factors, 
such as increased recognition, increased early detection by pediatricians / 
teachers, and broadening of the concept from the classic childhood autism 
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described by Kanner to the more extended phenotypes (i.e. autism spectrum 
disorders [Wing, 1996]) (see Annex 1 – Figure 2). For example, subjects who 
would have been diagnosed with mental retardation according to earlier criteria 
would be now additionally diagnosed with autism, a phenomenon which is called 
‘diagnostic accretion’ (Baxter et al., 2014; Parellada et al., 2014; Weintraub, 
2011). 
 
Annex 1 – Figure 2. Potential reasons underlying the raise in autism 
diagnoses since the 1970s 
 
 
From (Weintraub, 2011). Permission for reprint granted by Nature Publishing Group through 
Copyright Clearance Center (‘CCC’). 
 
 
 The increase in prevalence due to the potential effect of increasingly 
common environmental factors, such as the increased rates due to advanced 
paternal or maternal age (King, Fountain, Dakhlallah, & Bearman, 2009; Kong et 
ANNEXES 
193 
 
al., 2012) or the effect of new environmental toxins (Landrigan, 2010; Rossignol 
& Frye, 2012) is also under study - please refer to section 1.2.2.3. ASD, Etiology 
and physiopathology). 
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Annex IIa. ASD and psychotic disorders: overlaps in clinical features, social 
cognition and neuropsychological deficits 
 
Autistic characteristics can be present both before and after the diagnosis of 
psychotic disorders (Mouridsen, Rich, Isager, & Nedergaard, 2008; Sporn et al., 
2004; Tsakanikos, Sturmey, Costello, Holt, & Bouras, 2007) while a proportion of 
children with ASD may present with psychotic-like symptoms (Kyriakopoulos et 
al., 2015). Moreover, these neurodevelopmental disorders frequently co-occur (J. 
Rapoport et al., 2009), with numerous studies showing how a significant 
proportion of youth with psychotic experiences or schizophrenia fulfill criteria for 
ASD or present with marked developmental abnormalities during childhood 
(Alaghband-Rad et al., 1995; Bevan Jones, Thapar, Lewis, & Zammit, 2012; 
Eggers, Bunk, & Krause, 2000; J. Rapoport et al., 2009; Sporn et al., 2004; 
Sprong et al., 2008). Of note, pre-existing ASD is as frequent as 30-50% in 
childhood-onset schizophrenia (COS) cases and may appear many years before 
schizophrenia is diagnosed (J. Rapoport et al., 2009). The same applies to 
individuals with adult onset schizophrenia (Mouridsen et al., 2008; Selten, 
Lundberg, Rai, & Magnusson, 2015; Unenge Hallerback, Lugnegard, & Gillberg, 
2012).  
 
Furthermore, although autism and schizophrenia, as traditionally described, 
are quite distinct clinically (e.g. different age at illness onset, different symptom 
profiles [Konstantareas & Hewitt, 2001; Rumsey, Andreasen, & Rapoport, 1986; 
Spek & Wouters, 2010]), both disorders show a range of common / overlapping 
clinical features. For example, premorbid and early negative symptoms of 
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schizophrenia (e.g. early social withdrawal, flat affect, poor eye contact) are 
sometimes indistinguishable from symptoms present in individuals with autism. 
The language difficulties in ASD and schizophrenia (e.g. restricted dialogue or 
poverty of speech or even neologisms) can also easily be confused. Besides, not 
only patients with ASD but also those with schizophrenia can present with odd 
mannerisms and stereotyped behaviours and with rigid, inflexible pattern of 
thinking and behaving (Delahunty, Morice, & Frost, 1993; Leung & Zakzanis, 
2014; Ridley, 1994). Catatonia has also been described as a common phenotype 
for both ASD and schizophrenia patients and indeed there are descriptions of 
children presenting with mixed forms of catatonia, autistic and psychotic 
symptoms (Shorter & Wachtel, 2013).  
 
Deficits in higher order social cognition, including deficits in social 
reciprocity and theory of mind are hallmarks of ASD (Baron-Cohen, 1989) but can 
also be present in schizophrenia (Frith, 1992). Indeed, both patient groups 
present with difficulties in integrating information from the external and internal 
world and in the perception / understanding of self (e.g. self-awareness) and 
others (e.g. identifying emotions or intentions in other people), resulting in a 
limited ability to interpret (or understand) reality and themselves, and to generate 
appropriate responses to external demands (Addington & Rapoport, 2009; Bolte 
& Poustka, 2003; Couture et al., 2010; Crespi et al., 2010; Pinkham et al., 2008; 
J. Rapoport et al., 2009; Roberts & Penn, 2013; Sugranyes et al., 2011). ASD 
and schizophrenia (and other psychotic disorders) also share numerous 
neuropsychological deficits, including impairments in executive function and 
cognitive flexibility, abstract reasoning, and goal-directed problem solving 
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behaviours, as well as impaired general functioning as measured with the 
intellectual quotient (Mayes & Calhoun, 2008; Pennington & Ozonoff, 1996; 
Tiihonen et al., 2005). Neurological soft signs (NSS) are also a vulnerability 
marker in schizophrenia, reflecting abnormal brain maturation (Bombin, Arango, 
& Buchanan, 2005), but patients with ASD have also been noted to display 
sensorimotor impairments (Halayem et al., 2009). One study compared the 
prevalence of NSS in a sample of patients with Asperger’s syndrome, EOP and 
healthy controls and did not find significant differences between the groups of 
patients in their NSS profile (Mayoral et al., 2010). 
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Annex IIb. ASD and psychotic disorders: shared genetic, environmental 
factors and neurobiological underpinnings  
 
Although several lines of genetic evidence supporting the distinction 
between COS and autism emerged initially (Sporn et al., 2004), further evaluation 
of all studies suggested some common genetic abnormalities associated with 
both disorders (J. Rapoport et al., 2009). Furthermore, both disorders share 
environmental risk factors (e.g. higher parental age, intrauterine infections, 
maternal stress or immune disorders) which, in the interplay with genetics, might 
lead to similar (although probably distinct in time-sensitivity) changes in neuronal 
maturation, migration, synaptic integrity, and neurotransmitter functions (Meyer 
et al., 2011) 
 
Neuroimaging studies have also reported abnormal structure and function 
of brain regions associated with social cognition both in subjects with ASD 
(Pelphrey, Adolphs, & Morris, 2004) and psychosis (Bertrand et al., 2008). For 
example, volumetric GM deficits (Giedd et al., 2015), microstructural WM 
changes (Dwork, Mancevski, & Rosoklija, 2007; Ke et al., 2009) and abnormal 
brain gyrification (Kates et al., 2009; Palaniyappan & Liddle, 2012) have been 
reported as early vulnerability markers for both disorders. However, few 
neuroimaging studies have directly compared brain structure or function between 
these patient groups (Pinkham et al., 2008; Radeloff et al., 2014; Toal et al., 
2009). Indeed, the main available information on the neurological overlaps and 
differences between ASD and schizophrenia comes from reviews and meta-
analyses that put together findings from studies comparing each group separately 
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with healthy controls. (Abdi & Sharma, 2004; Cheung et al., 2010; Sugranyes et 
al., 2011). For example, fMRI studies show that ASD and schizophrenia patients 
both share activation deficits in similar brain regions within the ‘social brain 
network’ (e.g. hypoactivation within the superior temporal sulcus while performing 
a theory of mind task), and also demonstrate deficits unique to each condition 
(e.g. hypoactivation of thalamus unique to schizophrenia) (Sugranyes et al., 
2011). 
   
 
 
 
